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ABSTRACT
Though the study of the human proteome (proteomics) is far more complicated than
that of the genome, it may prove to be the next step toward gaining insight into the
operation of biological systems. Understanding the role proteins and peptides play in
disease, whether that be by their structure, expression or function, could lead to the
identification of disease biomarkers for diagnosis or engender possibilities for treatment.
To this end, the work discussed herein delves into the capillary electrophoretic (CE)
analysis of amyloid beta conformations involved in abnormal aggregation and the
creation and optimization of a novel bioassay method.

By rapidly analyzing the

conformations of Aβ present in heterogeneous mixtures, valuable insight may be
provided into the mechanism of abnormal protein aggregation.

Further, the novel

bioassay described herein may supply a simplified method for analyzing and quantifying
many different biologically relevant interactions (i.e. DNA hybridization and
immunoassays).
Capillary electrophoresis is used to study the aggregation pathway of the amyloid beta
peptide (Aβ). Since little is known about the mechanism of Aβ fibril formation, this
research sought to rapidly characterize different conformations of Aβ present in a
heterogeneous mixture of species using changes in effective mobility and peak shape
during CE separation. Electron microscopy and mass spectrometry were used to confirm
the presence of Aβ in the mixtures and collected peak fractions. Additionally, the
interaction between wild type Aβ and a mutated Aβ species resulting in increased
protofibril formation was analyzed using CE.
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A novel bioassay method was also developed and termed magnetically assisted
transport evanescent field fluoro-assays (MATEFFs). MATEFFs employ magnetic beads
as both a solid phase for analyte pre-concentration and delivery method to a localized
evanescent field.

Using this technique, the measurement of signal can be performed

without call for wash steps and while avoiding matrix interferents present in bulk sample
solution. While not limited by analyte diffusion, this method still allows for targeted
delivery using simple magnetic control of analyte-labeled beads. This could impact the
bioassay field, as much focus is currently directed toward miniaturization of bioassay
formats.
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PREFACE
The research presented in this dissertation spans my time in two research groups. Part I
covers the research efforts under the supervision of Dr. S. Douglass Gilman in capillary
electrophoretic analysis of amyloid beta peptides.

Part II encompasses the work

performed under the supervision of Dr. Michael J. Sepaniak in development and
optimization of a novel bioassay method. I have attempted to combine the two individual
projects under the general theme of biomedical methods of analysis.
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Part I .
CAPILLARY ELECTROPHORETIC SEPARATION OF
DIFFERENT AMYLOID BETA CONFORMATIONS ALONG
THE FIBRILLOGENESIS PATHWAY
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CHAPTER 1.
INTRODUCTION TO CAPILLARY ELECTROPHORESIS AND
PROTEIN AGGREGATION
Coupling

the

separation

power

of

electrophoresis

with

chromatography

instrumentation and ease of automation, capillary electrophoresis (CE) has become a
versatile analytical tool capable of separating a wide variety of compounds. Owing to
plug like flow and limited sources of dispersion, CE possesses the highest resolving
power of any liquid separation method, while consuming only minute sample quantities
and requiring minimal analysis time.1 Often, a simple change of buffer solution in CE
facilitates the analysis of a spectrum of relevant samples with various physicochemical
properties,

ranging

from

metal

ions

to

proteins.

Furthermore,

capillary

electrochromatographic (CEC) techniques, whereby CE capillaries are packed with high
performance liquid chromatography (HPLC) packing and a voltage is applied for
separation, are relatively new and offer both the differential partitioning of HPLC and the
electrophoretic migration of CE with no back pressure and plug like flow characteristics.
CEC techniques lead to uniquely selective separations and promise superior resolving
power as compared to traditional HPLC.

With increasing complexity in analytical

samples, especially those biological in nature, CE and CEC will continue to be essential
separation techniques due to consequent rapid analysis, high efficiency, and minimal
sample consumption, even with the existence of some disadvantages such as low sample
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load and difficult reproducibility. The work discussed in this section of the dissertation
will focus on traditional capillary zone electrophoresis.

Capillary Electrophoresis Fundamentals
History and Theory
Electrophoresis is simply defined as the migration of charged species when influenced
by an applied electric field, with separation of these charged species a result of
differential migration times owing to disparity in charge, size and shape.2 As ions move
toward the electrode of opposite charge under the influence of an externally applied
electric field, frictional drag balances the electric force and a steady-state is reached with
ion velocity (ν e ,cm sec-1) being directly proportional to the strength of the electric field
(E):

ν e = μe E

(1-1)

where μ e is the electrophoretic mobility of the ion (cm2 V-1 sec-1) and
E=

V
LT

(1-2)

where V is the total applied voltage and LT is the total length of the separation medium
(cm).

The physical parameters of the analyte affect mobility as evidenced by the

following equation:

μe =

q
6πηr

3

(1-3)

where q is the ion charge, η is the buffer viscosity and r is the ion radius. It is then
evident that small, highly charged species have high electrophoretic mobilities.3
First described by Tiselius in 1930, classic free solution electrophoresis suffered from
such problems as long analysis times, poor efficiencies, difficult detection and
automation, and joule heating arising from ionic current passing between electrodes.4
Joule heating can increase zone broadening due to density and temperature gradients, as
well as lead to solvent evaporation.

Introducing a support medium to aid in heat

dissipation, such as a gel, combatted the problem of Joule heating. However, the high
surface area available for solute adsorption when using a support, as well as an increase
in the possible routes of migration, increase zone broadening due to eddy diffusion.
Furthermore, the addition of the support medium served to make free solution
electrophoresis an even more labor intensive technique.2, 5, 6
Though early experimentation with free solution electrophoresis in capillaries dates
back to 1967, capillary electrophoresis (CE) in its modern form was developed in the
early 1980s by Jorgenson and Lukacs, thereby solving many problems of classic
electrophoresis.7 In CE, fused-silica tubes with inner diameters typically ranging from 20
to 200 μm and lengths between 10 and 100 cm are used as the migration channel. The use
of these narrow bore capillaries meant a high surface-to-volume ratio and concomitant
efficient heat dissipation even when applying large electric fields.

Resultant

improvement in separation efficiency and decreased analysis time coupled with
minimized reagent requirements made CE a very attractive solution to analytical
problems associated with other separation methods.8

4

Instrumentation
The instrumentation employed for capillary electrophoretic separations is relatively
simple. As shown in Figure 1.1, the basic CE system contains a narrow-bore, fused silica
capillary whose ends are immersed in electrolyte buffer reservoirs, with said buffer filling
the inside of the capillary. Each buffer reservoir contains an electrode connected to a
high voltage power supply, by which an external potential is applied across the capillary.
As separations are typically performed from the anode to the cathode (normal polarity),
the sample is loaded by removing the capillary from the buffer reservoir containing the
anode and placing the end into the sample reservoir where an external pressure or electric
field is applied. The sample reservoir is then replaced by the buffer reservoir and an
electric field or external pressure is again applied in order to perform the separation.
Detection can be performed online in capillary electrophoresis by simply removing the
polyimide coating so that a window is formed on the end of the capillary opposite that of
injection.3
Once injected into the capillary, analytes move under the influence of the applied
electric field by two independent processes: electrophoresis and electroosmosis.9 The
net analyte movement is the vector sum of these two processes (Figure 1.2). Normal
polarity conditions would result in migration of only the cationic species toward the
cathode, with neutral species remaining stationary at the point of injection and anionic
species being driven toward the anode and thus away from the detector. Only by the
process of electroosmotic flow can all ionic species be driven through the capillary and
thereby detected.

5

Detection & Data
Acquisition

Anode

+

Cathode

Buffer inlet

Buffer outlet
High voltage
power supply

Figure 1.1 Capillary Electrophoresis Instrumentation Schematic
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N
N

EOF
N

N

Figure 1.2 Illustration of net analyte movement in capillary electrophoresis as the vector
sum of electrophoretic solute migration and electroosmotic flow.
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Electroosmotic Flow (EOF)
Electroosmosis, playing a fundamental role in capillary electrophoretic separations, is
solvent flow originating at the solid-liquid interface of the capillary wall due to the
applied electric field. This flow is often referred to as the electroosmotic flow (EOF).5
EOF occurs when exposed silanol groups (SiOH) along the inner surface of the capillary
wall begin to ionize as SiO- at buffer pH values above 2 due to the range of silanol pKa
values.

These anionic silanol groups interact electrostatically with buffer cations,

forming a double layer comprised of both the stern layer (fixed and held tightly by the
silanol groups) and the diffuse layer (mobile layer pulled toward the cathode once the
electric field is applied).

This double layer creates a potential difference, or zeta

potential, along the capillary wall. When a potential is applied across the capillary under
conditions of normal polarity, these solvated buffer cations drag the bulk solution toward
the cathode and thus the detector (Figure 1.3).10

The velocity of the bulk solution

traveling through the capillary due to EOF (νEOF, cm sec-1) is given by:
v EOF = μ EOF ⋅

V
L

(1-3)

where µEOF is the mobility of the EOF (cm2 V-1 sec-1), V is the voltage applied across the
capillary and L is the total length of the capillary (cm).7 The net migration velocity of an
analyte traveling through the capillary (v), then, is the sum of νe and νEOF:5

ν = (μ e + μ EOF ) ⋅

8

V
L

(1-4)
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+

+
+
+

+

+

+
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+
+ + +
+ +
+ +
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+

+
+

+
+

+

+ +
+
+

+
+

+ +

Figure 1.3 Representation of the double layer formed at the capillary surface
upon application of an electric field.
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Normally, the magnitude of the EOF is greater than the electrophoretic mobilities of the
analytes present in a sample. This leads to the separation of cations, anions and neutrals
(as a group) in a single run with the order of migration depicted in Figure 1.2.3 It is
important, though, to control EOF as slow EOF could result in zone broadening and
increased analysis time. Several factors influence EOF including buffer pH and ionic
strength, temperature, and electric field.

Ultimately, anything that affects the inner

capillary wall and, therefore, the zeta potential will impact EOF.
A very important additional benefit of EOF is the flat profile of the bulk flow due to
the fact that the driving force of the flow arises at the capillary walls.11 This flat profile
leads to negligible zone broadening due to resistance to mass transfer in the mobile
phase, in sharp contrast to the laminar or parabolic flow resulting from pressure-driven
systems such as HPLC.12 Laminar flow can result in significant zone broadening due to a
velocity gradient, where the solvent velocity in the center is high and drops to zero along
the walls.13

While EOF aids in high resolution separations and, in theory, only axial

molecular diffusion occurs in CE, several factors may result in dispersion by their affect
on EOF or otherwise.14
Efficiency and Resolution
Ideally, the lone contributor to band broadening in CE is axial diffusion and the
equation for efficiency (or theoretical plate number, N) is given below
N=

μEl
2D

(1-5)

where µ is mobility (cm2V-1sec-1), E is applied electric field (Vcm-1), l is the capillary
length to the detector, and D is the diffusion coefficient of the solute (cm2sec-1). It can
10

then be inferred that high voltages will increases theoretical plates and improve efficiency
by minimizing the time for diffusion and that CE can be highly efficient for both large
and small molecules due to the high mobility of small compounds and low diffusion
coefficients of larger molecules.15 Unfortunately, other dispersive factors can contribute
to band broadening and loss of efficiency in CE.
Although the small dimensions of the capillaries employed for CE separations help to
efficiently dissipate heat, with the tens of kilovolts separation voltages normally used for
efficient separations, joule heating can contribute to band broadening due to changes in
buffer viscosity.6 Adsorption of molecules to the capillary surface, aside from changing
the zeta potential and EOF, could result in distortion of peak shape. Peak fronting or
tailing could also result from sample overload or from differences in conductivity
between the running buffer and sample (electrodispersion).12 Additionally, injection plug
length and hydrostatic flow can play a role in band broadening. All of these dispersion
factors can be avoided by a general attentiveness to experimental design including
judicious choice of buffer concentration, sample ionic strength and concentration, and
capillary coatings
High efficiency is the “claim to fame” of CE and is undoubtedly important; however,
the ultimate goal in separation science is resolution. Under conditions such that axial
diffusion is the sole source of band dispersion, the resolution (R) between two solutes in
CE is defined as
R = 0.177 Δμ

V
D ( μ + μ eof )

11

(1-6)

where Δμ is the difference in mobility between the two solutes, μ is the average
mobility of the two solutes, μ eof is the electroosmotic mobility, V is the applied voltage
and D is the diffusion coefficient of the solute.15 Factors that linearly increase efficiency,
voltage for example, come under the square root sign and do not linearly affect
resolution. The effects of joule heating limit the application of voltage increases to
improve resolution. From equation (1-6), infinite resolution is attained when the average
and electroosmotic mobility are equal and opposite. This is not possible, however, since
it also results in infinite analysis time. The goal, then, is to balance resolution and time
by manipulating EOF.

Detection Methods in Capillary Electrophoresis
Detectors used in CE must be highly sensitive, a consequence of the minute sample
volumes injected and limited observation time for this technique.

Unfortunately, a

problem arises in that the most sensitive detectors are also the most selective.4 A very
sensitive, but also universal method of detection in CE would be very useful. The most
common means of on-column detection are optical methods, such as ultraviolet (UV)
absorbance and fluorescence.

Optical methods of detection do face instrumental

problems such as short optical path lengths defined by the inner diameter of the capillary
and the cylindrical capillary’s poor optical surface .15 Laser-based detection can solve
these problems since laser light sources can be focused to very near the diffraction limit
of light and collection of emitted light at right angles to the excitation source can
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eliminate stray light using spectral and spatial filters.16 In addition to optical methods,
electrochemical detection and mass spectrometry find application in CE.
UV Absorbance Detection
UV absorption is the most popular detection system for capillary electrophoresis due
to its universal nature. On-column detection is achieved by removing a window of
polyimide coating from the capillary near the end of the column. This window serves as
the cell where UV detection is performed. Sensitivity in absorbance detection is limited
by the path length, which is defined by capillary inner diameter. However, this method is
attractive because a large number of analytes, especially proteins, absorb quite well in the
UV range.5 The limits of detection for UV absorbance are around 10-6 M, but can be
optimized by choosing the wavelength for optimal molar absorptivity, using a buffer with
minimal UV absorbance, as well as extending the pathlength of the capillary.15
Multiwavelength or scanning UV detection systems can be used in order to detect
analytes absorbing at different wavelengths in the same run or determine spectral
information of an unknown.13
Laser-Induced Fluorescence (LIF) Detection
Fluorescence detection is attractive because sensitivity is not dependent upon the pathlength. In LIF detection, a laser serves as the excitation source and is tightly focused on
the window where the polyimide coating has been removed, with emitted light is usually
collected at 90° relative to the incident laser beam. Employing lasers as the excitation
source, much smaller capillaries can be utilized, as lasers can be focused to nearly the
diffraction limit of light.16 The detection limits for on-column LIF detection are the
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lowest reported for CE, with routine LODs around 10-9 M.17 However, with this high
sensitivity comes increased selectivity. Commercial lasers are either a fixed wavelength
or tunable over a small range, with a limited selection of available laser wavelengths. At
each available laser wavelength, only select chemical species absorb with high emission
quantum efficiency.16 In addition, not all analytes of interest exhibit native fluorescence.
This introduces an additional derivatization step so that non-fluorescent analytes can be
detected.
Mass Spectrometric Detection
Coupling CE to mass spectrometry (MS) is attractive due to the combination of
sensitivity and structural information provided by MS.12 Though MS is one of the most
expensive CE detectors, when dealing with complex, especially biological, samples it is
necessary to identify the components based on something more reliable than migration
time.

For direct detection, electrospray has been the preferred ionization method,

although continuous flow-fast atom bombardment, matrix assisted laser desorption
ionization, and atmospheric pressure chemical ionization have been employed. Most
major types of mass analyzers have been used with CE, including quadrupole, magnetic
sector, time of flight; ion trap and Fourier transform ion cyclotron resonance. Detection
limits for CE-MS have been reported in the attomole or zeptomole range and CE-MS
continues to develop, both instrumentally and functionally.8
Electrochemical Detection
Electrochemical (EC) methods of detection in CE are attractive due to the possible
high selectivity and sensitive detection of electroactive species without derivatization.
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Detection limits are in the attomole range and not at all affected by the small dimensions
of CE. Additionally, instrumentation is relatively inexpensive in comparison to other
detection methods. The major dilemma in the use of EC detection with CE is the noise
arising from high separation potentials native to CE separations. It becomes important to
develop a method which isolates the EC signal.18 Though conductivity, a non-selective
and simple method of ionic species detection in solution, was the earliest form of EC
detection with CE, current EC detection methods include amperometry, potentiometry
and scanning electrochemistry.
Laser Light Scattering (LLS) Detection of Particles
Light scattering detection techniques have not been extensively used in CE. However,
this method has some advantages over other detection methods.

LLS detection is

performed by focusing a laser beam on the detection window of the capillary and
detecting the light scattered (usually at angles 15-180° from the incident beam) as the
analyte passes through the window. This detection method is based on the concept that
scattered light contains information, such as size and refractive index, about the scattering
particle.19 Mie scattering theory can be used to characterize light scattering distributions
taking into account the effects of particle size, refractive index, detection angle and
geometry.20 LLS detection is attractive because it is capable of measuring the properties
of individual particles passing through the laser beam one at a time (using the appropriate
data collection rates and a tightly focused laser beam) and not the average properties of a
population of analyte particles. This allows particles to be individually counted and the
scattered light intensity of each particle to be related to its size. However, LLS is not a
15

selective technique, as any system contaminants or particulates, such as bubbles, large
enough to scatter light will produce a background scattering signal. However, with a
contaminant-free system, detection limits can be as low as 1000 particles/mL.21 Lower
size detection limits for LLS detection have not been fully explored, although reliable
detection of particles as small as 110 nm has been reported.22, 23 LLS is especially useful
in mixtures of protein or other biological macromolecules because it is a non-invasive
detection method that does not require tagging or dilution. Changes in particle numbers,
density, length and diameter can be measured and these changes can provide important
information about such things as aggregation pathways of proteins.19
Indirect Detection
With CE being an attractive method of separation for all kinds of compounds, a
universal detection method is desirable.

Indirect detection methods, whether UV

absorbance, fluorescence or electrochemical, offer just that. When an analyte does not
have any native UV absorbance or fluorescence, a component of the buffer is used to
absorb light or fluoresce, producing a constant buffer signal in the absence of analyte.
When analyte is present, it displaces some of the buffer ions and results in a negative
peak proportional to amount of analyte present.5 Indirect detection methods frequently
suffers from .column overloading and band broadening, with detection limits related to
buffer absorbance and stability of transmitted light.18

Modes of Capillary Electrophoresis
In attempt to expand the number of applications of CE, several modes of operation
have been developed geared toward the separation of different types of compounds.4
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Most of these methods are variations of electrophoresis that were adapted to the capillary
format.

The most common modes of capillary electrophoresis are capillary zone

electrophoresis (CZE), micellar electrokinetic chromatography (MEKC) and related
pseudo-phase techniques, size selective capillary electrophoresis (SSCE), capillary
isoelectric focusing (CIEF), and capillary isotachophoresis (CITP).18
Capillary Zone Electrophoresis (CZE)
Being the simplest and most popular, CZE will be the method used in the research
discussed herein. In CZE, essentially free solution electrophoresis, the buffer is the same
in the reservoirs and the capillary. The analyte migrates in zones under the influence of
the applied electric field depending upon the charge/size ratio.2 It is important, in order
to achieve a good separation with CZE, that the mobilities of each analyte in the injected
sample differ from one another, that the buffer is homogeneous throughout the capillary,
and that there is no interaction of the solute or matrix with the capillary wall. Separation
of both cations and anions are possible, owing to EOF, while neutrals coelute with EOF.
Micellar Electrokinetic Chromatography (MEKC)
MEKC, introduced by Terabe in 1984, allows separation of neutral species.

A

surfactant above the critical micelle concentration is added to the running buffer and
neutral solutes partition into the micelles. The retention factor determines the order of
separation for the neutral species, making MEKC much like reverse-phase high
performance liquid chromatography (RP-HPLC).24 Sodium dodecyl sulfate (SDS) is the
most common micellar phase used in MEKC. The micellar phase is referred to as
pseudostationary since, in the case of anionic SDS, it moves slower than the mobile
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phase.

In addition to micelles, charged cyclodextrins, polymers, bile salts, and

microemulsions have been employed as pseudostationary phases. The peak capacity for
MEKC is limited by the elution range determined by the difference between the EOF (t0)
and the micelle migration time (tm).18
Size Selective Capillary Electrophoresis (SSCE)
In order to permit size based separations, a sieving matrix can be formed within the
capillary or pumped in under high pressure. This matrix can be in the form of a gel or an
entangled polymer.

Analyte migration is still driven by the electric field, but also

affected by the required migration through the gel or polymer matrix. This results in
analyte mobility inversely proportional to size under ideal conditions, as small molecules
easily pass through pores while larger biomolecules may travel an arduous path.15
Capillary Isoelectric Focusing (CIEF)
CIEF separates proteins and peptides based on their isoelectric point (pI) using a pH
gradient formed inside the capillary by a solution of ampholytes.

Ampholytes are

zwitterionic and have pI values than span a range of pH values (usually 3 to 9). The
capillary is filled with an analyte containing solution of ampholytes and the gradient is
formed by placing the cathode in basic solution and the anode in acidic solution followed
by application of an electric field. The charged ampholytes and analytes will move under
the influence of the electric field until they reach a region where they become uncharged
(their pI). Once this focusing is complete, current no longer flows and the zones are
passed by the detector either by a separate mobilization step in the absence of EOF,
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simultaneous focusing and mobilization via careful control of EOF, or mobilization of the
detector or capillary.12
Capillary Isotachophoresis (CITP)
Literally meaning moving at the same speed, CITP utilizes a leading and trailing
buffer system to create separated analyte zones moving at the same velocity toward the
detector. Used to detect either cations or anions, the leading buffer contains the highest
mobility ion and the trailing buffer the lowest mobility ion. The analyte containing
sample is injected between these two zones and the analytes separate in order of mobility.
The highest mobility compounds have the lowest field strength and vice versa.
Therefore, all the zones, once equilibrium is reached, will move at the same velocity
(refer to equation (1-1)). With no carrier electrolyte, the zones will remain in contact
with one another. A major advantage of CITP is the compression of low concentration
analytes resulting in trace component enrichment.2

Capillary Electrophoretic Peptide Separations
An important application of CE is in the area of bioanalytical chemistry, more
specifically the separation of peptides and proteins. In the post genomic era and with
emerging proteomic technology, the ability to rapidly separate mixtures of peptides and
proteins is of utmost importance.

Proteome research will provide insight into the

molecular basis of biological processes and aid in development of targeted drug
therapies. With protein structure and function determined by their peptide fragments,
now more than ever it is important to understand the peptide makeup of cells (the
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peptidome).25

CE has found utility in monitoring of enzymatic peptide digests,

determining purity of peptide synthesis and in isolating individual peptides from complex
mixtures.26 Due to high efficiency and ability to resolve small differences in solute
mobility, CE is capable of resolving peptides with the same charge, but differing in mass
by one amino acid, as well as peptides that have the same mass but differ in charge by
one. CE is non-denaturing, allowing separation of polypeptide molecules in their native
states. In comparing CE to complementary techniques in chromatography, such as RPHPLC, CE is faster and less labor-intensive.27 Furthermore, the fact that polypeptides
and proteins have small diffusion coefficients increases separation efficiency in CE,
whereas these small diffusion coefficients lead to slow mass transfer between stationary
and mobile phase, increased band broadening and reduced separation efficiency in
chromatography.6 However, a key limiting factor for CE, especially when applied to
proteome research, is the limited sample loading capacity. This can be detrimental in
terms of the dynamic range provided when interfacing CE with other analytical
techniques, such as mass spectrometry.
Predictive models for peptide migration are necessary for analysis of large numbers of
peptides contained in cells and tissues. There is a correlation between the electrophoretic
mobility of peptides and their charge, size and shape. The best fit theoretical model for
predicting peptide mobility, μ p , is the Offord model which accounts for a shear factor
related to peptide surface area.28 This model proposes that

μp =

q
M

2
3
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(1-7)

where q is the charge of the peptide molecule and M is the molecular weight. It can be
difficult to predict the charge of a peptide, however, as a function of pH since pKa values
of amino acid groups in peptides may differ from that of amino acids in free solution.
A major application of CE is found in characterization of peptides and their
consequent proteins.

The monitoring of dynamic changes in peptide preparations,

whether chemical modifications or physical alterations, can provide useful insight into
denaturation, folding/unfolding and conformational states.25 The separation, analysis and
characterization of peptides by CE is attractive due to the advantages of high efficiency,
small sample consumption, and ease of automation, but not without challenges.5
A continuing challenge in the analysis of peptides with CE is the suppression of
adsorption to the capillary wall. Polypeptides have a high affinity to adsorb on the fusedsilica capillary wall believed to be due to electrostatic interactions between positively
charged residues and negatively charged silanol groups on the inner wall of the capillary.
This issue, if not addressed, results in a loss of separation efficiency, poor reproducibility
and low recovery.29 In dealing with this problem, coatings can be used to shield the
silanol groups and eliminate sites for adsorption. However, the coating procedure is
laborious and has a limited lifetime. Buffer additives, such as cationic surfactants or
polymers, are another option to reduce peptide-capillary interactions. In these cases, high
ionic strengths are usually required, resulting in problems with Joule heating. Perhaps
the simplest approach is to manipulate the pH of the buffer to a value well above the
isoelectric point (pI) of the peptide, so that it is negatively charged and repulsed by the
anionic charges on the capillary inner surface.29 As with any CE separation method,
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appropriate buffer conditions, electric field strength and capillary length, among other
things, must be ascertained for successful peptide separations.

Capillary Electrophoretic Analysis of the Amyloid Beta Peptide
The amyloid-β peptide (Aβ) is comprised of 39-43 amino acid residues and is the
proteolytic product of the amyloid precursor protein (APP).

Aβ is the primary

constituent of the extracellular amyloid fibril deposits found in the brains of Alzheimer’s
disease (AD) patients, in addition to being associated with more than 20 other amyloid
diseases.30

There are many lines of evidence suggesting that Aβ fibril formation plays a

central role in the onset of AD. The overexpression of mutant APP by transgenic animals
leads to the development of amyloid plaques made up of fibrillar Aβ. In addition, the
mutations associated with early onset familial AD all lead to increased production and/or
deposition of Aβ in the brain. Moreover, several mutations affecting the processing of
APP result in increased levels of Aβ, particularly the more amyloidogenic Aβ42 (the 42
amino acid variant of Aβ peptide).31, 32
There is current debate as to the exact identity of the toxic agent in AD. It has been
demonstrated that Aβ fibril formation proceeds via a complex multi-step polymerization
mechanism involving nucleation and elongation steps (Figure 1.4).31 Recent research
suggests that the toxic form of Aβ may not be the insoluble fibril species, but rather the
soluble oligomeric intermediate state in the mechanism.

These intermediates are

sometimes referred to as protofibrils. Recent evidence better correlates the protofibril
content of Aβ in the brain with the severity of AD than the fibril content.31-33 Exploration
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Aβ Monomer

Aβ Intermediate
Aggregate
(Protofibril)

Aβ Fibril

Figure 1.4 Aggregation scheme for amyloid beta (Aβ) peptide. Electron micrographs
represent the protofibril and fibril species.
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of the role of protofibrils in amyloid assembly could lead to a better understanding of AD
and suggest a method for inhibiting amyloid pathogenesis.
There has been very little reported on the analysis of Aβ peptides by CE. Varesio et
al. report the use of CE coupled to electrospray mass spectrometry to detect Aβ 1-40
peptide, but do not attempt to determine the conformational species present in the
sample.34 CE separations of different length Aβ fragments have also been reported.35,
36

However, no attempts are made to identify the conformation of Aβ producing the

observed peaks.

Changes in peak shapes or peak mobilities are attributed to aggregation

or different species along the aggregation pathway.

Motivation for Aβ Characterization by CE
Developing a method for elucidation of the components of a heterogeneous mixture
containing Aβ species present during fibril formation would facilitate investigation of the
fibrillogenesis process. CE provides an avenue to rapidly explore Aβ populations in real
time under mild conditions while consuming minimal material. The efficiency of CE
allows separation of oligomeric species that differ slightly in mass, charge or shape,
which could result in discrimination between the different conformations of Aβ along the
pathway to fibril formation, not possible using many other analytical techniques.
Calibration can be performed using well characterized particles, such as polystyrene
spheres, in order to better understand changes such as mobility and peak shape for the
separation of more complex peptide and protein mixtures. The work described herein
will seek to rapidly characterize Aβ species using CE, with confirmation of their identity
by electron microscopy and mass spectrometry. A better understanding of Aβ
24

aggregation, and protein misfolding in general, would aid in diagnosis of amyloid related
diseases as well as, and more importantly, the evaluation of possible therapies for their
treatment and/or prevention.
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CHAPTER 2.
ANALYSIS OF AMYLOID BETA CONFORMATIONS USING
CAPILLARY ELECTROPHORESIS

Introduction
Protein aggregation normally represents the failure of a protein to reach the correct
spatial arrangement, folded state, in order to function properly. If the proper fold is not
attained, the protein acquires an abnormal conformation, misfolded state, or abnormally
persists in an intermediate state which would normally be transiently visited along the
folding pathway. In these misfolded states, unusually large non-polar areas of the protein
are exposed and extremely sensitive to intermolecular hydrophobic interactions with
other misfolded proteins, resulting in aggregation. 37
The accumulation of these misfolded proteins is a common feature in several
neurodegenerative disorders. Moreover, a class of late-onset, slow-progressing diseases
seem to result from the gain in function of these misfolded aggregate states.38 The
extracellular deposition of aggregated protein is a hallmark of Alzheimer’s disease (AD),
while intracellular protein aggregation characterizes Parkinson’s disease, amyotrophic
lateral sclerosis and polyglutamine disorders.39 The structure of these disease-related
protein deposits is commonly referred to as the amyloid fibril. Amyloid fibrils are
normally rigid and unbranched structures with a diameter of 5-13 nanometers and a
length of up to several microns. Genetic evidence, as well as the correlation between
fibril deposits and disease, suggest that fibril formation is pathogenic.40 It is important to
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gain a better understanding of the mechanism by which protein misfolding, and
ultimately fibril formation, occurs in order to therapeutically battle the neurodegenerative
diseases characterized by this phenomenon.
The amyloid β (Aβ) polypeptide family is the primary constituent of extracellular
fibril deposits isolated from the brains of AD patients, in addition to being associated
with more than 20 other amyloid diseases.41 The Aβ monomer is a 39-43 amino acid
residue peptide that is the proteolytic product of the amyloid precursor protein (APP).
The predominant species generated by APP metabolism is the 40 amino acid residue
peptide (AβWT), although many other species can be produced including the more
amyloidogenic 42 amino acid peptide, Aβ1-42.42 It has been demonstrated that Aβ fibril
formation proceeds via a complex multi-step polymerization mechanism whereby
monomer is converted to a soluble oligomeric intermediate, or protofibril, that disappears
upon further aggregation into the fully formed fibril species.31 There are many lines of
evidence suggesting that Aβ fibril formation plays a central role in the onset of AD
including the increase in Aβ production and/or deposition by the mutation associated
with early onset AD and increased levels of Aβ created by mutations affecting APP
processing.31, 41
There is current debate as to the exact identity of the toxic agent in AD, with recent
research suggesting that the toxic form of Aβ may not be the insoluble fibril species, but
rather the soluble protofibril.32, 41 It has been discovered that protofibril content better
correlates with AD severity than fibril content, and a mutation of the Aβ peptide
associated with early onset familial AD called the Arctic mutation (AβARC),
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an

autosomal dominant mutation of the Aβ monomer at the 22nd amino acid residue (E22G),
when compared to AβWT, forms protofibrils more rapidly and to a greater extent. This
suggests that early onset AD resulting from this mutation could be due to the toxic
protofibril species.41, 43 However, with protofibril formation being a normally transient
process along the pathway to fibrillization, detailed characterization of protofibril
structure is rendered difficult.
Williams and coworkers, using a screening assay for Aβ aggregation stimulators,
found that calmidazolium chloride (CC) is particularly effective in stabilizing
protofibrils.44 When adding 100 μM CC to AβWT monomer, the monomer is rapidly
converted to a pelletable aggregate or protofibril that persists for days. This stabilization
will permit more detailed analysis of these intermediates and possible determination of
their role in the aggregation process.
In the present work, capillary electrophoresis is used to separate samples of AβWT
monomer, calmidazolium chloride stabilized protofibrillar aggregates (CC-AβWT), and
fully formed AβWT fibrils.

Additionally, AβARC is separated and compared to AβWT

monomer. As previously mentioned, this mutation serves to promote the formation of
stabilized protofibrils and speeds up fibrillogenesis when mixed with AβWT monomer.
CE is attractive for these separations due to the advantages of high efficiency, small
sample consumption, and ease of automation.5

The presented work shows a clear

distinction between the electrophoretic mobility and peak shape of monomer and fibril
species. In addition, the stabilization of an intermediate aggregate by calmidazolium
chloride allows for the interrogation of this otherwise transient species. The isolation of
the different conformational species of Aβ along the aggregation pathway (i.e. monomer,
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protofibril, and fibril) in the preparation steps reported herein, confirmed by electron
microscopy, warrant the conclusive identification of the observed peaks resulting from
each species.

Collected peak fractions were analyzed using matrix assisted laser

desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) to confirm the
presence of Aβ. Furthermore, fibrillogenesis was monitored over a period of several days
using CE to separate a mixture of AβWT and AβARC monomers. The observed data was in
agreement with published reports indicating the acceleration of fibrillogenesis in mixed
solutions of AβWT and AβARC. The separations herein provide a means for rapid species
identification based on a difference in mobility as well as a simple avenue for monitoring
aggregation and exploring the effect of aggregation inhibitors or accelerators.

Experimental
Materials and reagents
Tris-HCl (tris(hydroxymethyl)aminomethane hydrochloride) and calmidazolium
chloride were purchased from Sigma (St. Louis, MO). TFA (trifluoroactetic acid) was
purchased from Pierce (Rockford, IL). HFIP (1,1,1,3,3,3-hexafluoro-2-propanol) was
purchased from Acros (Suwanee, GA). All buffer and stock solutions were prepared in
deionized, distilled water from a Barnstead Epure System (18MΩ resistivity, Newton,
MA) except for calmidazolium chloride, which was prepared at a concentration of 1 mM
in DMSO (dimethyl sulfoxide).
Monomer, protofibril, and fibril preparation
Chemically synthesized AβWT(1-40), amino acid sequence DAEFRHDSGY
EVHHQKLVFF AEDVGSNKGA IIGLMVGGVV, and AβARC (1-40 Arctic (E22G))
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peptides were purchased from Keck Biotechnology Center (Yale University). These
peptides were disaggregated in order to remove any preexisting aggregates by a
TFA/HFIP protocol as previously described.30 The disaggregated peptides were then
lyophilized for one hr and dissolved stepwise in equal volumes of 2 mM NaOH and 2X
PBS (pH 7.4), containing 0.1 % sodium azide, to a final peptide concentration of
approximately 50 μM. The samples were then centrifuged to remove any remaining
aggregates (AβWT overnight at 315000 g and AβARC for 30 min at 13000 g). The
supernatant concentration was checked using HPLC, and the monomer solutions were
removed for CE analysis at this point. In order to form CC-Aβ aggregates, the AβWT
monomer was combined with calmidazolium chloride to a final concentration of
approximately 30 μM AβWT monomer and 100 μM calmidazolium chloride in 1X PBS
containing 10 % DMSO from stock calmidazolium chloride solution. Fibril samples
were prepared by incubation of the monomer in 1X PBS at 37 °C for approximately 7
days. Thioflavin T assay was used to monitor fibril growth.45 For AβWT and AβARC
mixture samples, the monomer samples were combined in a 1:1 ratio.
Capillary Electrophoresis Separations
All CE separations were performed using a Beckman Coulter P/ACE™ MDQ CE
System. The instrument was equipped with a UV source and wavelength selectable UV
detector with which absorbance detection was performed at 214 nm.

Fused silica

capillaries (50 μm inner diameter, 358 μm outer diameter; 60 cm total length, 50 cm to
detector) were placed in the capillary cartridge and thermostatted at 25 °C along with the
sample holding chamber. At the beginning of every day, the capillary was flushed
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sequentially at 20 psi with the following solutions: 1 M HCl for 10 min, Epure water for
2 min, methanol for 5 min, Epure water for 2 min, 1 M NaOH for 10 min, Epure water
for 2 min, and 10 mM Tris-HCl, pH 7.8 running buffer for 5 min. Between runs, a 20 psi
buffer flush was performed for 5 min.
A buffer exchange step was performed on all peptide solutions in order to replace the
high salt PBS buffer with one more compatible with CE separations. Microcon® YM-3
centrifugal filter units (Fisher) were used as directed for buffer exchange procedures on
AβWT monomer peptide samples. For CC- AβWT aggregates and AβWT fibril samples, a
centrifugation step (30 min at 13000 g) was used to pellet out the peptide. The PBS
buffer was then removed and the peptide was washed with 10 mM Tris-HCl. This wash
step was repeated again before a final resuspension of peptide in 10 mM Tris-HCl.
Pressure injections were used (5.0 s at 1.0 psi) and the applied separation potential was
12 kV, producing an electric field of 200 V/cm for all samples.
For AβWT and AβARC mixture separations, PBS buffer was exchanged using
Microcon® YM-3 centrifugal filter units, with the centrifugation step carried out in a
refrigerated centrifuge to avoid aggregation.

The monomer mixture was then

resuspended in 2 mM Tris-HCl. Electrokinetic injections were used for these samples
(5.0 s at 10 kV), with a separation potential of 12 kV, producing an electric field of 200
V/cm.
Data was acquired using 32 Karat™ Software Version 5.0 from Beckman Coulter.
Peak fractions were collected using the Manual Fraction Collection feature and
specifying appropriate peak elution times and peak widths. Thirty consecutive CE runs
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were performed, with peaks collected, for each sample. All data was exported and
analyzed using Microsoft Excel®.
Matrix Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry
(MALDI-TOF MS)
Mass spectra of collected peak fractions (collected as described above) were acquired
on an Applied Biosystems Voyager DE-PRO™ MALDI-TOF MS, equipped with a 20
Hz repetition rate nitrogen laser (337 nm). The instrument was controlled by Voyager
Version 5.0 Software with Data Explorer™ and operated in the linear mode. CHCA (αcyano-4-hydroxycinnamic acid) matrix was prepared in acetonitrile/H2O (50:50, v/v)
containing 1.0 % TFA to a final concentration of 10 mg/mL and combined with equal
volumes of peptide sample from collected peak fractions. The samples were then spotted
on a standard 100 well stainless steel MALDI sample plate. Laser power was adjusted for
each sample spot, with 200 shots acquired per spectrum.
Electron Microscopy
AβWT samples in 10 mM Tris-HCl (fibrillar and protofibrillar) were adsorbed onto
glow-discharged carbon-coated copper grids.

Grids were then stained with freshly

prepared 0.75 % uranyl formate. A Hitachi H-800 electron microscope operated at 100
kV was used to inspect the specimens, and images were taken at 50,000x nominal
magnification.
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Results and Discussion
Monomer
The monomeric form of amyloid beta peptide is normally present in human plasma
and cerebrospinal fluid (CSF), with the 40 amino acid variant the most common.36
However, upon pathogenesis, the peptide begins to aggregate into soluble oligomers and
insoluble fibrils that are deposited in the brain. The 40 amino acid AβWT monomer
samples used in this work were prepared according to the procedure outlined above to a
final concentration of 38 µM. Analysis of the separation of the AβWT monomer species
by CE reveals two peaks (Figure 2.1). The first peak was well-resolved, reproducible and
attributed to AβWT monomer, while the second peak is believed to be a system peak as it
was not consistently present from run to run. The baseline dip in Figure 2.1, which
appears after the monomer peak, is the result of the fraction collection programming
during which time the end of the separation capillary was transferred to another sample
vial for peak collection. Approximately 30 CE fractions were collected and analyzed
using MALDI-TOF MS. The inset of Figure 2.1 depicts the observed MS peak, which
corresponds to the molecular ion, [M+H]+, of AβWT (4330.5 Da). The weak MALDI MS
signal could be the result of the low peptide concentrations from CE fraction collection or
the inefficient MALDI ionization of the Aβ peptide due to limited basic amino acid
residues. Based on its pI value of 5.2, AβWT monomer migrated under its anionic form,
and the peak retention time was changed to electrophoretic mobility using a neutral
marker.46 An electrophoretic mobility of -1.22 x 10-4 cm2 V-1sec-1 was observed for the
monomer peak, with this mobility and peak shape remaining constant throughout
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Figure 2.1 Electropherogram of 38 μM AβWT monomer sample injected for 5.0 s at 1.0
psi into a capillary filled with 10 mM Tris-HCl, pH 8.0. Manual fraction collection was
used to collect monomer peak, and the inset depicts the collected MALDI-TOF mass
spectrum from the monomer fraction.
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multiple injections. Prior to CE separation, the monomer sample was spotted on a
copper grid for EM analysis. As expected, there were no discernable shapes in the EM
images due to the small monomer size and inadequate resolution of the electron
microscope (Figure 2.2A). However, this did confirm that aggregate species were not
present in the monomer sample, as they would be obvious in the EM images.
Aggregate
Studies suggest that the neurotoxic species in AD may be the soluble intermediate
(protofibril).47 However, because they are transient in the fibrillogenesis process and
tend to dissociate in buffer solutions, they prove difficult to analyze using many
biophysical techniques. Calmidazolium chloride (CC) was previously found to interact
with soluble Aβ, resulting in a rapid conversion to a pelletable aggregate species. This
interaction did not increase the signal from a Thioflavin T (ThT) fluorescence assay used
to measure fibril formation, suggesting that the aggregate species induced by CC
resemble a protofibril, and not mature fibril, species.44 In the work reported herein, CCAβWT aggregate samples were prepared according to the procedure outlined above to a
final aggregate concentration of 29 µM. Analysis of the separation of the CC-AβWT
aggregates by CE revealed a single, narrow peak with electrophoretic mobility of -1.55 x
10-4 cm2 V-1sec-1 attributed to CC-AβWT, as well as a peak representing mesityl oxide
used as the neutral marker (Figure 2.3). The fact that CC-AβWT elutes after the monomer
species is presumably a result of the greater negative charge of the aggregate species
resulting in an increase in electrophoretic mobility. The presence of CC seems to lead to
a clustering of individual protofibrils, possibly facilitated by CC binding. Because CC is
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Electron micrographs of A) AβWT monomer;

chloride stabilized aggregate; C) AβWT fibril species.
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Figure 2.3 Electropherogram of 29 μM CC-AβWT aggregate sample injected for 5.0 s at
1.0 psi into a capillary filled with 10 mM Tris-HCl, pH 8.0. Manual fraction collection
was used to collect the aggregate peak, and the inset depicts the collected MALDI-TOF
mass spectrum from the aggregate fraction.
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used to stabilize the protofibrillar intermediate aggregate, the normally transient species
between the monomer and fully formed fibril can be analyzed using CE. The dip present
in the electropherogram is, again, a result of the fraction collection method. The inset of
Figure 2.3 illustrates the mass spectrum from the collected CC- AβWT fraction with a
molecular ion peak at 4328.4 Da. The CC-AβWT sample, prior to CE separation, was
spotted onto copper grids for EM analysis. The electron micrographs revealed large,
fine-structured spheroids similar to previous reports of isolated protofibrils characterized
by EM, but no fully formed, mature fibril species (Figure 2.2B).31, 48
Fibril
Deposition of insoluble, fully formed fibrils in the brains of AD patients is a hallmark
of the disease. Fibrils are normally long unbranched filaments with widths of ~10 nm
and varying lengths up to several microns. The AβWT fibrils used in the experiments
reported herein were prepared according to the procedure outlined above to a final
concentration of 51 µM. Analysis of AβWT fibril separation by CE revealed a broad
collection of peaks with a range of electrophoretic mobilities from -1.98 x 10-4 to -2.88 x
10-4 cm2 V-1sec-1 (Figure 2.4). The range of peaks is a result of the heterogeneous nature
of the fibril sample. Once again, the fact that the fibril peaks elute after the monomer and
protofibril species under conditions of normal polarity presumably indicates that this
AβWT species possesses a greater negative charge relative to the radius change, resulting
in increased electrophoretic mobility. The peaks corresponding to the fibril species were
again collected using manual fraction collection and analyzed using MALDI-TOF MS to
confirm the presence of AβWT. The peak corresponding to the molecular ion appears at
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Figure 2.4 Electropherogram of 51 µM AβWT fibril injected for 5.0 s at 1.0 psi into a
capillary filled with 10 mM Tris-HCl, pH 8.0. The separation potential was 20 kV.
Manual fraction collection was used to collect the fibril peak, ,and the inset depicts the
collected MALDI-TOF mass spectrum from the fibril fraction.
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4330.1 Da, as shown in Figure 2.4. In addition, the EM images from this sample reveal
the characteristic long, unbranched rod-like fibril structure (Figure 2.2C).
MALDI-TOF Analysis
Fractions of all CE separated AβWT samples were collected and analyzed using
MALDI-TOF MS as discussed in the experimental section. Each collected fraction
produced a single, representative peak in the mass spectra resulting from the [M + H]+
ion of AβWT peptide, which has a molecular weight (MW) of 4328.9 Da (i.e. a molecular
ion [M + H]+ of 4329.9 Da). Although the peaks in each of the three mass spectra
(monomer, aggregate, and fibril) are slightly different in mass, they are all within the
mass accuracy of the instrument for the MW of AβWT. The MS results confirm that the
peaks collected from each of the separations did indeed contain AβWT peptide. Since the
peaks exhibited quite different electrophoretic mobilities, the only conclusion is that they
represent different conformational species of AβWT along the pathway to fibrillogenesis.
AβWT and AβARC Mixture
A mutation of APP, where glutamic acid at the 22nd amino acid residue of the amyloid
peptide is substituted for glycine (E22G), termed the Arctic mutation (AβARC), results in a
decrease of AβWT in the plasma of carrier individuals, as well as an increase in protofibril
formation in vitro.

This suggests that the AβARC mutation initiates an alternate

pathogenic mechanism for AD manifestation, possibly implementing the protofibril as
the primary neurotoxic species.49 Since carriers of the Arctic mutation are heterozygotes
and express both AβARC and AβWT, it is of interest to understand the in vitro behavior of
mixed solutions. Previous studies showed that addition of AβWT to AβARC samples
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stabilized the protofibril species, with the protofibril primarily comprised of AβARC.41
For studies reported herein, monomer samples of AβWT and AβARC were prepared as
outlined above to a final concentration of 21 µM and 18 µM, respectively. Initially, a
monomer control sample for each Aβ species was separated using CE. Subsequently,
AβWT and AβARC samples (55 µM) were mixed together in a 1:1 ratio and incubated at
room temperature in PBS for the duration of the experiment. Each day, a sample was
removed from the mixture and the buffer exchanged for CE separation. The AβARC and
AβWT monomer species had different electrophoretic mobilities of -1.12 x 10-4 and -1.47
x 10-4 cm2 V-1sec-1, respectively (Figure 2.5). It is interesting to note the difference in the
mobilities for these two Aβ species, as they differ only in one amino acid residue.
However, the replacement of glutamic acid at position 22 by glycine results in a loss of
charge for AβARC as compared to AβWT, resulting in a decrease in electrophoretic
mobility. For the first separation after mixing of the two monomer solutions (day 0), the
monomer peak is split because it results from a mixture of AβARC and AβWT monomer
species. The original separations seen in Figure 2.5 were before the use of a refrigerated
centrifuge and a second peak in the AβARC monomer and mixture separations can be seen.
This peak is believed to be caused by aggregation accelerated by the centrifuge. A
refrigerated centrifuge was used in all subsequent separations. Samples were extracted
from the incubating monomer mixture each day and separated using CE. Figure 2.6
depicts the change in separation of the mixture throughout the experiment. An aggregate
peak can be seen growing in at longer incubation times as the AβARC peak begins to be
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Figure 2.5 Electropherogram of 21 μM AβWT (red), 18 μM AβARC (blue) and a 1:1
mixture (55 μM) of the two species (black). All samples were injected for 5.0 s at 10 kV
into a capillary filled with 2 mM Tris-HCl, pH 8.49.
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Figure 2.6 Electropherograms of 55 µM 1:1 AβWT:AβARC mixture from day 1-9 of the
fibrillogenesis process. All samples were injected for 5.0 sec at 10 kV into a capillary
filled with 2 mM Tris-HCl, pH 8.49. The inset highlights depletion of the AβARC peak as
fibrillogenesis proceeds.
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depleted relative to the AβWT monomer peak (Figure 2.6 inset). This result supports
earlier findings that AβWT monomer stabilizes protofibril intermediates formed by AβARC
monomers, but is preferentially excluded from the protofibril and fibril species.41 This
would cause the AβARC peak to be diminished more quickly that the AβWT monomer.

Conclusions and Future Work
Part I of this dissertation highlights the decisive identification of three conformational
species of Aβ along the aggregation pathway (monomer, aggregate and fibril). This is the
first report of the separation and conclusive identification, using electron microscopy and
mass spectrometry, of the aforementioned Aβ conformations. Clear distinctions are made
in electrophoretic mobility and peak shape for each conformation of Aβ analyzed.

The

results reported herein would make possible rapid species identification and screening of
aggregation accelerators or inhibitors.

Moreover, the separations performed on the

AβARC:AβWT mixture demonstrate the ability to monitor aggregation of Aβ peptides over
time, possibly shedding light on the elusive mechanism of aggregate and fibril
formation.37,
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Work on this project is ongoing and recent experiments support the

findings reported herein. Additionally, continuing work established a detection limit of 4
µM for the monomer species of Aβ at a signal to noise ratio of 3.50 ThT fluorescence
studies of the Aβ fibrillization process correlated well with the results of CE separation
and proved the importance of monomer sample preparation, as in vitro studies are
extremely susceptible to experimental conditions used in sample preparation, and the
presence of any aggregate species in a monomer sample will accelerate fibrillogenesis.
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CHAPTER 3.
INTRODUCTION TO IMMUNOASSAYS AND EVANESCENT
SENSING

Taking advantage of the specific affinity of an antibody for its target antigen,
immunoassays have developed into one of the most fruitful contributions to medicine and
life science of the last century. Dating back to 1900, the immunoassay concept originated
with the blood typing research of Ehrlich and Landsteiner.51 The modern immunoassay
was detailed in the late 1950’s with the investigation of diabetes by Berson and Yalow.52
In their research, they experimented with radiolabeled and unlabeled insulin and
described the first radioimmunoassay, winning the Nobel Prize in 1977.

Today,

immunological techniques are involved in over one billion clinical tests annually in the
United States alone, ranging from drug tests to pregnancy tests. However, immunoassay
utility has not been confined to the medical field, as they have found application in
environmental, food, pharmaceutical, veterinary and forensic sciences.53 In addition to
the range of applications, there have been many novel and clever immunoassay designs
introduced which sought to enhance sensitivity, simplify protocols, and/or increase
throughput. The concept of Magnetically Assisted Transport Evanescent Field Fluoroassays (MATEFFs) aims to reconcile the advantages of some current immunoassay
strategies while implementing, for the first time, a localized evanescent sensing surface
and magnetic delivery of a target analyte to the surface for detection.
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Immunoassay Theory and Basics
The Antibody
It is serendipitous that nature provides the key element used in the study of so many
biological processes. The antibody is a protein belonging to the immunoglobulin family,
and is produced in humans and animals in response to some foreign substance, or antigen.
The most common class of immunoglobulin and that which provides the majority of
antibody based immunity is IgG, although there are also IgM, IgA, IgD, and IgE
subclasses with different biological properties and response to antigen. The typical
structure of IgG is illustrated in Figure 3.1. Each type of antibody is made up of a Yshaped monomer unit comprised of four polypeptide chains: two identical heavy chains
and two identical light chains connected by disulfide linkages. Each light chain has a
molecular weight of about 25,000 Da and is composed of both a variable (VL) and
constant domain (CL). The heavy chains, with a molecular weight of 50,000 Da (making
the entire antibody structure ~150,000 Da), contain one variable domain (VH) and three
or four constant domains (CH1, CH2, CH3) depending upon the subclass. The variable
domains, at the two tips of the Y structure, differ in amino acid composition and
determine the antibody specificity for a particular antigen.

Antibodies can be

proteolytically digested into Fab, F(ab’)2 and Fc fragments, depending upon the cleaving
enzyme employed. Papain cleaves above the disulfide linkages which act as a hinge,
forming two Fab fragments and the Fc portion, while pepsin cleaves below the hinge
leaving one F(ab’)2 portion and the Fc portion. The Fab and F(ab’)2 fragments are
responsible for antigen binding, with the Fc portion mediating the physiological effect
upon antibody response.
47

en
tig g
A n ndi n
Bi

Heavy
Chain

Variable
Region

Light
Chain

Fixed
Region

Fc
Portion

Papain
Digest

Pepsin
Digest

F(ab’)2
Portion

Fab
Portio

Figure 3.1 Basic IgG structure and the Fab and F(ab’)2 products produced by protease
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Antibodies can be elicited against a large variety of compounds (antigens), both
natural and man-made, as a result of the enormous number of possible amino acid
sequence combinations within the binding site. Once obtained, the antibody is specific
for its target antigen (more so than most other reagents), able to bind to diminutive
concentrations of analyte in the presence of many similar substances. Small molecules
that are not able to stimulate an immune response on their own, termed haptens, can be
attached to a large carrier molecule (bovine serum albumin, for example) for antibody
generation in response to the hapten-carrier adduct. One of the resulting antibodies may
then be specific for the small molecule even in the absence of the carrier molecule,
facilitating generation of an antibody for a molecule that would otherwise be
unrecognizable to the immune system. Further, with the development of recombinant
techniques allowing rapid cloning and DNA characterization, antibodies are now being
engineered to produce specific functional properties for a desired application.54
The strength of binding between an antibody and its antigen is dependent upon the
sum of these contributing non-covalent forces; electrostatic interactions, hydrogen
bonding, Van der Waals forces, and hydrophobic interactions.

Van der Waals and

hydrophobic forces operate over short distances due to structurally similar surfaces, while
electrostatic interactions and hydrogen bonding are a result of specific reactive groups
shared by the antigen and antibody. Though antibody-antigen interactions are noncovalent, the affinity of an antibody for its antigen can be quite high. The affinity
constant (Ka) measures the “tightness” of binding between one antibody binding site and
the antigen epitope for which it is specific, and represents the ratio of bound to unbound
analyte. At equilibrium
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Ka =

[ Ag − Ab]
[ Ag ][ Ab]

(3-1)

where [Ag] represents concentration of free antigen, [Ab] signifies free antibody
concentration, and [Ag-Ab] corresponds to the concentration of antigen-antibody
complex.55 Typical affinity constants for IgG antibodies are 105-109 L/mole, but some
antibodies can have affinity constants as high as 1013 L/mole.56 Sometimes, a better
measure of binding in a biological system is the antibody avidity, which represents the
overall binding between an antibody and antigen This includes binding between multiple
epitopes of an antigen and the different binding sites for the antibody (IgG has two
possible binding sites).57
Antibodies can be either monoclonal or polyclonal, and both are useful depending
upon the immunoassay application. Polyclonal antibodies (PAbs) are a result of classical
immune response whereby an injected antigen stimulates production of many antibodies,
recognizing several epitopes on the antigen. Because of the heterogeneity of PAbs, the
effect of small changes in an antigen epitope is less likely to be significant. Additionally,
PAbs are stable in a range of pH and salt concentrations, and less likely to be altered by
covalent attachment of a fluorophore or other reporter molecule.

Since PAbs are

produced by a large number of B cells in response to the antigen and are therefore a
combination of antibodies with unique specificities, they are generally more specific than
monoclonal antibodies (MAbs).57 MAbs, first developed by Kohler and Milstein some
30 years ago, are produced when single B-cells are fused with immortal myeloma cells to
produce a hybridoma that can yield multiple copies of the exact same antibody.58,

59

MAbs are homogenous and consistent, making them quite useful when evaluating
50

conformational changes or protein interactions. However, this homogeneity renders them
much more susceptible to small changes in epitope structure. MAbs are constantly
generated once a hybridoma is successfully created, making them a renewable resource.
Furthermore, MAbs are generated at a higher concentration and purity for a given
antibody than PAbs. The generation of MAbs is expensive, time consuming, and requires
considerable technical skill as compared to PAbs. This is not an issue, however, if the
antibodies are readily commercially available. The decision of whether to use PAbs or
MAbs is, again, dependent upon the intended use. In summary, PAbs are generally more
robust, can be generated by a variety of species, and are more tolerant of small
conformational changes in the antigen. MAbs, on the other hand, are excellent primary
antibodies because of their specificity and yield reproducible results due to their
homogeneity.

Immunoassay Classification
Competitive vs. Non-competitive
Immunoassays can normally be categorized as either competitive (reagent limited) or
non-competitive (reagent excess).

Competitive assays normally require a fixed

concentration of labeled antigen (or tracer) that competes with unlabeled antigen for a
limited number of antibody binding sites. The signal from this form of competitive
assay, as it is generated by the tracer antigen, is inversely proportional to the
concentration of unlabeled antigen in the sample. An example is illustrated in Figure
3.2A. Alternatively, the antibody can be labeled and allowed to react with bound antigen
in the presence of an antigen containing sample solution. After washing, the signal from
51
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B

Figure 3.2 A) Competitive immunoassay illustration (solid phase separation). B) Noncompetitive immunoassay illustration.
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the labeled antibody bound to the surface is measured and is, again, inversely
proportional to the sample antigen concentration.
In a non-competitive assay (sandwich) format, the antigen is normally bound by two
antibodies; one that acts as the capture antibody and one that is labeled and acts as a
reporter antibody.

An example is shown in Figure 3.2B.

In this case, the signal

generated is directly proportional to the concentration of analyte. In order to carry out a
sandwich assay, the antigen of interest must contain two separate epitopes, or antibody
binding areas.33, 58
When choosing between non-competitive and competitive assay designs, several
factors must be considered. Normally, small molecules are analyzed using a competitive
immunoassay format since they offer only one site for antibody binding. Additionally,
competitive assays are sometimes preferred when analyzing a broad range of analyte
concentrations. Non-competitive assays, on the other hand, have many advantages over
competitive assays. They are normally faster and easier to use on-site, have greater
specificity for the target analyte, and boast lower limits of detection.60-62 For these
reasons, the sandwich assay design will be implemented in the work discussed in this
dissertation.
Homogeneous vs. Heterogeneous
Immunoassays are also classified as either homogeneous or heterogeneous, depending
upon whether or not a solid phase is employed. Homogeneous assays do not require the
separation of bound and free analyte/antibodies before signal measurement. In these
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cases, the act of binding between the antibody and antigen results in some modulation of
signal that can be detected in the presence of free antigen and antibody (Figure 3.3A).
The level of modulation is a factor in limiting sensitivity since there must be a clear
differentiation between signal and background. Homogeneous immunoassay strategies
involve turbidity measurement, fluorescence protection, fluorescence energy transfer, and
fluorescence polarization, to name a few.53,

63-65

The use of homogeneous assay

techniques is obviously attractive as it simplifies the steps and decreases the time
required for the immunoassay.

In theory, the homogeneous assay should be more

sensitive than its heterogeneous counterpart, as complicated and possibly denaturing
wash steps are avoided. However, the sample matrix proves to be a formidable foe when
attempting to decrease background signal. Furthermore, many homogeneous assays do
not realize the full potential of decreased analysis time since the addition of several
reagents is required prior to detection.
In heterogeneous assays, either the antigen or antibody is immobilized on a solid
support surface. After allowing sufficient time for binding between the antigen and
antibody, a wash step removes the free antigen or antibody before signal measurement
takes place (Figure 3.3B). It is advantageous to remove the sample matrix, especially in
those cases where the matrix is biological in nature with the presence of many possibly
interfering species. Furthermore, solid-phase immunoassays facilitate concentration of
the bound complex on a surface for detection, such as in the case of strip kit pregnancy
and ovulation tests. However, heterogeneous assays are generally time and reagent
consuming, as the antibody or antigen must diffuse to the solid surface for binding to take
place and multiple wash steps diminish throughput and, sometimes, sensitivity.66, 67
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Figure 3.3 A) Example of homogeneous immunoassay. B) Example of heterogeneous
immunoassay format (before wash steps).
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Labels
Virtually all immunoassays rely on the use of a label for signal generation. There are
a variety of labels currently employed in the immunoassay field including, but not limited
to, radioisotopes, enzymes, fluorophores and particles.68 Radioimmunoassays (RIAs),
introduced in the 1950s, were very common in early immunoassay research.
Radioisotopes are unstable atom variants that spontaneously emit energy in the form of
particles or electromagnetic particles as they decay to a more stable state. The half-life,
or time required for half of the radioisotope to decay, is specific to each isotope
employed, with the most commonly used isotope being Iodine 125 (half life of 60
days).53 Radioisotopes are easily detected with minimal interferences, but require a
separation step, special detection equipment, and special precautions for disposal.68
Enzyme labels, introduced in the 1970s, are now the most widely used immunoassay
label.

Benefiting from the catalytic properties of enzymes to generate colored,

fluorescent or luminescent compounds from neutral substrates, detection limits for
enzymeimmunoassays (EIAs) can be quite low. However, signal generation in EIAs is
susceptible to interferences from temperature, pH, and possible enzyme inhibitors.
Consequently, special skill and experience is required in order to optimize not just the
antibody-antigen interaction, but the production of signal.69 The most commonly used
enzymes for EIAs are horseradish peroxidase and alkaline phosphatase, with different
substrates employed depending upon the signal source chosen.
Fluoroimmunoassays (FIAs) have gained in importance to the immunoassay field due
to the inherent sensitivity of fluorescence spectrometry, commercial availability of a large
56

number of fluorophore labeled antibodies, and the increase in availability of costeffective lasers for excitation. Fluorophores absorb light of a specific wavelength, and
emit a photon of longer wavelength as they return to the ground state. This process can
occur many times until some chemical damage or modification results in loss of the
ability to fluoresce. FIAs suffer from high background, especially in biomedical analysis,
as a result of scattering and autofluorescence from the sample matrix and are sensitive to
temperature, pH and dissolved oxygen. The difference between excitation and emission
wavelength (Stokes shift) should be maximized in order to minimize noise from incident
light scatter, and the quantum efficiency, or proportion of absorbed energy that is reemitted, should be as close to a value of 1 as possible. Fluorescein, rhodamine and their
derivatives are most commonly employed in FIAs. More recently, quantum dots have
become attractive fluorescent reporters with their high quantum yields, sharp emission
spectras, chemical and photostability, tunability, and long shef-lives. These features
make them quite attractive for multiplexing and ultrasensitive applications.70

All

immunoassay research in this dissertation made use of FIA techniques.71
Finally, particles ranging from dyed latex to colloidal gold to liposomes have been
used as labels in immunoassay. Dyed latex labels are employed in some over-the-counter
pregnancy tests in order to produce a visually recognizable response. Colloidal gold has
been used as a label in order to aid in visualization by electron microscopy or to allow
measurement of optical property changes upon binding and aggregation. Additionally,
liposomes can be used in agglutination reactions upon immunocomplex formation or
liposome lysis resulting in release of a trapped marker can be used for amplification.53, 68

57

Current Efforts in Immunoassay
The current push in immunoassay development, as in so many other areas of science,
medicine, and technology, is toward miniaturization.

The microarray immunoassay

offers the ability to detect multiple analytes simultaneously in the same sample using
spatially isolated individual immunoassays on a solid surface. Theoretically, these assay
formats can be at least as sensitive as their macroscopic counterparts.

It is imperative

that antibody affinity and the number of active capture antibodies be maximized for
microarray formats to be successful. This will require superior binding capacities on the
solid surface and efficient binding strategies in order to retain maximum antibody
activity. Since antibody microarrays depend heavily upon mass transport to the surface
for binding, anything that improves the mass transport can potentially improve
sensitivity.62, 72, 73 The research efforts discussed in the following two chapters of this
dissertation attempt to improve upon current bioassay methods and address the issues that
will impact their success in the future.

Total Internal Reflection
Theory and Applications
When light travels across the boundary between two mediums possessing different
refractive indices, the beam will normally be both refracted and reflected. However,
under the special case where the light is traveling from a high index of refraction medium
to one with a lower refractive index and the angle of incidence at the interface is greater
than the critical angle, total internal reflection (TIR) will occur.

The critical angle is the

minimum incident angle at which TIR will occur, where the incident angle is measured
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with respect to the normal at the boundary. Applying Snell’s law, the fundamental law
governing the refraction of light, where the angle of refraction is 90º, the critical angle,

θ c , is given by
θ c = arcsin

n2
n1

(3-2)

where n 2 is the refractive index of the less dense medium and n1 is the refractive index
of the more dense medium. At the precise critical angle, light will be reflected along the
boundary between the two materials. At angles greater than θ c , the light will be totally
reflected except for an evanescent wave (EW) that penetrates into the lower refractive
index medium (Figure 3.4). Evanescent means “tending to vanish”, which is appropriate
considering the EW decays exponentially as it penetrates into the lower refractive index
medium with the penetration depth (d) given by 74, 75
d=

λ
4π n1 sin θ − n2
2

2

2

(3-3)

where λ is the wavelength of light and θ is the incident angle. The intensity of the
evanescent wave at a distance z from the interface, I(z), is given by
I ( z ) = I (0)e

−z
d

(3-4)

The most recognized application of TIR is in fiber optics, where this property of light
is used to transmit focused light without significant loss and revolutionized the
telecommunications industry. However, the localization of the evanescent field at the
interface makes it attractive from a spectroscopic standpoint. System design changes
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Figure 3.4 Total internal reflection in a prism with illustration of evanescent wave
formation.
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when the goal is not just to confine light within a TIR element, but to make use of the
EW radiation for probing materials on the TIR element surface.
Currently, attenuated total reflectance (ATR) is used for absorbance measurements of
samples (liquid or solid) directly in contact with an ATR crystal or prism. The shallow
EW is advantageous when analyzing thin films or samples that are too optically dense for
standard transmission techniques. Additionally, total internal reflectance fluorescence
(TIRF) can be used to interrogate fluorescent molecules that are either tethered or in close
proximity to a surface. With TIRF microscopy, developed in the early 80’s by Axelrod,
one can overcome the diffraction limit of light for excitation and illumination of
molecules or specimens immediately adjacent to a glass/liquid boundary.76 This has been
invaluable in selective visualization of cell membranes, as well as cell-surface
interactions, molecular dynamics of DNA and unfolding of immobilized proteins.77-79
With the introduction of microarray technology, detection of bioanalytical system
interactions (hybridization or antigen/antibody binding) using TIRF has appeal.80,

81

Target molecules from within a sample medium can be examined, taking advantage of
the high sensitivity provided by fluorescence spectroscopy, without significant
interference from the bulk matrix. TIRF will be implemented in the research discussed in
the following chapters of this dissertation.
Transducers
The reflection elements, or transducers, used for EW excitation can take several forms.
The transducer refractive index will determine the range of incident angles that can be
interrogated above the critical angle and, therefore, the possible range of penetration
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depths, making high refractive index materials the most popular choice. The simplest
structure is that of the prism, or single reflection element. Normally, a laser beam is used
to illuminate one edge of a prism, with the EW created at the base of the prism if the
incident angle is greater than the critical angle. The sample can be placed directly on the
prism base for examination. Using a right angle prism, TIR will take place once at the
prism base resulting in a single EW spot of uniform intensity with dimensions that
depend upon the laser spot size and focusing optics. The simplicity of laser coupling and
EW creation make this approach attractive for interface studies of cells, proteins and
DNA. However, the single internal reflection element design does not lend itself to
multiplexed applications.
Waveguides are structures that literally guide waves (electromagnetic radiation) by
way of repeated TIR. The cylindrical fiber optic, as mentioned above, is the most
common type of waveguide, but the discussion in this section will be limited to planar
waveguides. Bulk planar waveguides, a type of multiple internal reflection element, are
appealing because of their 2-dimensional surface which makes possible patterning of
multiple arrays or attachment of microfluidic architecture.

Bulk planar waveguide

thickness is large in comparison to the wavelength of incident radiation. One example of
a bulk planar waveguide is a simple microscope slide with a thickness of approximately 1
millimeter. In this arrangement, multiple modes of radiation are allowed at a given
wavelength.82 Coupling of radiation into a multi-mode waveguide is simple as it only
requires direction of the incident beam onto the end face of the waveguide at an
appropriate angle.
waveguide.

The light will then be confined and guided by TIR within the

The relatively large face of a bulk planar waveguide allows for slight
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changes in alignment without compromising efficient coupling. Further, bulk planar
waveguides are commercially available and inexpensive.

While the number of

reflections within the waveguide (NR) is a function of waveguide thickness (t), incident
angle (θ) and length of the waveguide (L) as given below,
NR =

L
2t tan(θ )

(3-5)

the evanescent field on the waveguide surface can be made essentially uniform.80
Cylindrical lenses focusht in only one axis, so that light focused by a cylindrical lens to a
narrow slit on the edge of the bulk waveguide will be guided in an un-collimated manner
through the waveguide with divergence of the beam in only the direction of propagation.
This results in an area of uniform EW illumination after just a couple of reflections that
will serve as a sensing field, as compared to several discrete EW spots without the use of
a cylindrical lens (Figure 3.5).
Integrated optical waveguide (IOW) thickness is comparable to the wavelength of the
propagating light. For this reason, there are approximately 103-104 reflections/cm of
beam propagation when using IOWs.83 This results in overlap of discrete reflections so
that they become virtually indistinguishable, resulting in high light intensity and
significant improvement in sensitivity over thicker bulk optical waveguides.80 Figure 3.6
compares a bulk waveguide to an IOW. However, other criteria come into play when
choosing the appropriate waveguide system. IOWs are typically able to support only one
mode of radiation, making coupling an issue. Simple end coupling is no longer an
option, and special prisms or grating are generally used in order to couple light into the
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Sensing Region

B
Cylindrical Lens

Figure 3.5

A)

Propagation of light through a waveguide without focusing.

B)

Propagation of light through a waveguide with cylindrical lens focusing to create an area
of uniform illumination.

64

A
d
twg

B
d

twg

Figure 3.6 A) Bulk optical planar waveguide regime. B) Integrated optical waveguide
regime.

twg denotes the waveguide thickness, with d representing the depth of the

evanescent wave.
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waveguide.

The angular alignment requirements are, therefore, very precise and

complicate IOW use. Furthermore, the mere creation of IOWs is quite a task. The
waveguide can be formed using solution phase techniques such as spin or dip coating,
normally used for polymer materials. Deposition procedures can also be employed,
creating sputtered or vapor deposited films. Ion exchange techniques can be used to
produce graded index waveguides with a gradual transition from the substrate to
waveguide refractive index. Additionally, sol-gel processing can be used to produce high
quality metal-organic thin films from solution phase processes. All of these techniques
require tolerances on the tens of nanometers scale and, as such, result in high cost of
fabrication and complicated processing steps.84

EW Technology and Immunoassay
While the field of immunoassay, and bioaffinity sensor systems in general, have
benefited from the use of evanescent wave excitation, there is a key drawback. Whether
using optical fibers or planar waveguides, the biological system of interest (antibodies,
proteins or DNA, for example) is immobilized on the waveguide surface using covalent
immobilization, physical adsorption, or entrapment within polymer matrices. The result
of this surface immobilization is limited mass transport. The assay is, then, diffusion
limited and signal may take hours or even days to develop.85

Magnetic Particles
Besides the hot research area of microfluidics and other miniaturized systems,
microparticles and nanoparticles are garnering much attention in the scientific
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community.

While functional microparticles or “beads” can serve as useful mobile

substrates in many bioassay formats, the advantages are compounded when the beads are
magnetic. Magnetic beads, aside from having the large surface-to-volume ratio and
amplified interaction of the surface with passing fluids, can be magnetically controlled
independent of normal fluid flow. This increases the relative bead motion with respect to
the surrounding fluid medium and enhances sample pre-concentration on the magnetic
bead surface.86 For fluid manipulation of beads, the magnetic force must be greater than
the hydrodynamic drag force acting on the particles. For this research, the use of an
external permanent magnet was sufficient to meet the above conditions. In general,
magnetic beads can have a single magnetic core (usually in the case of nanoparticles) or a
core composed of multiple magnetically interacting nanoparticles encapsulated in a nonmagnetic matrix. Commercially available magnetic beads, used in the research discussed
in this dissertation, are provided with various surface modifications and chemistries, high
iron content, and narrow size distribution.

These particles are superparamagnetic,

meaning they exhibit magnetic properties when in the presence of a magnetic field, but
have no residual magnetism once the magnetic field is removed, rendering them easily
recoverable in solution.

They additionally boast high magnetic mobility and low

sedimentation rates. Figure 3.7 illustrates the spherical shape and low sedimentation rate
of the commercial products used in the research discussed in the following chapters.
Magnetic beads have been employed for cell separation, immunoassays, DNA
hybridization studies and drug delivery.
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Figure 3.7 Illustration of slow sedimentation rate and excellent size distribution for 1 µm
Dynal magnetic beads. Photo Courtesy of Dynal Bead Based Separations (Invitrogen
Group)
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MATEFFs Design Rationale
Both homogenous and heterogeneous assay formats have benefits and drawbacks.
Selective sequestration of analyte on a solid surface, as with heterogeneous assays, has
advantages, but requires wash steps. The measurement of signal without need for wash
steps, as in a homogeneous assay, is attractive but normally results in background
interference.

MATEFFs utilize magnetic beads as the solid phase for analyte

sequestration, resulting in analyte concentration and subsequent delivery to a localized
field created by TIR for detection. This eliminates both the need for multiple wash steps
and background interference from bulk matrix components. The magnetic beads are
easily dispersed and recovered in solution, making it possible to not only regenerate the
EW sensing surface between measurements by simply removing the magnet that retains
the magnetic bead plug, but to fully interact with the sample solution without relying on
diffusion to a single spot on a planar surface.

This novel technique that cleverly

integrates, for the first time, concepts that have been researched and implemented for
decades is described and optimized in the following chapters.
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CHAPTER 4.
MAGNETICALLY ASSISTED TRANSPORT EVANESCENT FIELD
FLUOROIMMUNOASSAYS
Introduction
The immunoassay, a diverse suite of techniques combining chemistry and
immunology whereby an antibody is used in the determination of sample composition, is
a biomedical tool commonly used in toxicology, drug analysis and immunoscreening
procedures.87 Antibodies boast strong binding interactions and unique specificity with
their target antigen, making possible measurements of very low antigen concentration
even in complex matrices.33

The inherent sensitivity of fluorescence spectroscopy

combined with the existence of a wide range of commercial antibodies and labels renders
fluoroimmunoassays (FIAs) an attractive method of analysis.

The two principle

quantitative protocols for FIAs are heterogeneous assay, requiring a separation step to
remove bound target analyte from a sample mixture, and homogeneous assay, whereby
the target analyte is directly detected within the mixture.65 Homogeneous assays are
attractive due to the preemption of many laborious and time consuming steps necessitated
by the heterogeneous assay.

However, homogeneous assays suffer from limited

sensitivity and interference from fluorescent impurities present in the matrix, not to
mention the fact that many homogeneous assays actually require the addition of several
reagents before detection.65
Conventional immunoassays, performed in microtiter plates, consume large amounts
of expensive reagents and can take as long as a few days for target molecules to diffuse
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through solution and completely react with immobilized probes.88

Microfluidic

separation and fluid handling systems have garnered much attention in the past decade as
a portable, small footprint means of carrying out chemical and biological processes on a
manageable, solvent- and sample-conserving platform.89 It is logical, then, that the
immunoassay format could benefit from these miniaturized systems.

In fact,

homogeneous and heterogeneous immunoassays have been performed in capillaries and
microfluidic devices.66,

67, 90-92

For heterogeneous assay application, antibodies and

antigens were immobilized on microchips with multiple operations performed (loading,
washing and labeling) before detection.66, 67, 92 In the case of homogenous assays, some
sort of separation and detection step must follow antigen-antibody complexation in
solution. Two groups have reported electrophoretic separation of reaction products from
a competitive homogeneous assay.90, 91 However, separation can be difficult in systems
with small differences between free and complexed antigen or antibodies, limiting
widespread application of this technique.
Magnetic microspheres (μspheres) have found utility as solid phases for biomolecule
immobilization. In general, μspheres have several advantages when used as the solid
support in immunoassays, including a large specific surface for binding, mobility of the
solid phase, and an attendant enhancement in interaction of the phase surface with
passing fluids.

When the μspheres are magnetic, there are still more advantages.

Magnetic manipulation of μspheres independent of fluidic flow makes possible the
delivery of immobilized analytes, be they proteins or small molecules, to a specific zone.
These μspheres are practical, well tested, and readily commercially available with
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modifications that allow attachment of antibodies or other specific recognition groups,
thereby allowing analyte-specific sequestration within a complex matrix.

Finally,

magnetic μspheres are amenable to miniaturization and multiplexing using different
capture probes. In recent work, magnetic μspheres containing an immobilized antibody
were held stationary in a fused-silica capillary by an external magnet and used to capture
an antigen in solution, which was subsequently rinsed from the μspheres for downstream
detection.93 Additionally, a clever heterogeneous sandwich immunoassay was performed
in a simple microchannel using a stationary plug of magnetic μspheres as the solid phase
with antigen capture by one immobilized antibody and detection performed by imaging
fluorescence resulting from a second fluorescent antibody.94 Very recent work by Petkus
et al. uses magnetic bead rotation and lock in amplification to demonstrate that overall
assay sensitivity can be enhanced by eliminating the wash step, especially when dealing
with hapten derived monoclonal antibodies.95 These techniques demonstrate the utility
and reward of incorporating magnetic bead solid supports into microfluidic devices.
Nevertheless, there are some aspects of the microimmunoassay that can be optimized
before realization of the full potential of this method. For instance, the precise control
and formation of a small magnetic bead plug in a microchannel is not trivial.
Inconsistencies in bead plug packing density or length could greatly affect fluid
dynamics, flow rates, reaction rates, bead plug stability and reproducibility. Furthermore,
multiple labeling and wash steps required with the heterogeneous assay format, in
general, introduce the potential for non-specific adsorption anomalies, complicate sample
handling and increase time consumption.
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The current work seeks to reconcile the

advantages of solid support sample concentration with the need to eliminate complicated
separation steps by, for the first time, combining selective magnetic transport of analyte
to a highly localized evanescent electromagnetic field.
The work presented in this chapter serves as a proof of concept and details the
development and preliminary optimization of a novel technique, immunological
Magnetically-Assisted Transport Evanescent Field Fluoro-assays (MATEFFs), which
combines the advantages of both the homogenous and heterogeneous assay while
eliminating some of the drawbacks.96,

97

MATEFFs realize selective sequestration of

target analyte on magnetically controlled beads, affording the heterogeneous assay
benefit of low detection limits, while still allowing the delivery of the target from within
the bulk mixture to a localized evanescent field sensing surface.

Evanescent field

techniques make use of the property of total internal reflectance at an optical interface, in
this current illustration of MATEFFs defined as the interface between the prism and
sample.

Total internal reflection (TIR) occurs when light traveling from a higher

refractive index medium into a lower refractive index medium strikes the interface at an
angle larger than the critical angle.

The light is totally reflected, except for an

electromagnetic (evanescent) wave (EW) that is generated at the reflecting surface and
penetrates a fraction of a wavelength into the lower refractive index medium. The EW
intensity decreases exponentially with increasing distance from the interface.
MATEFFs employ magnetic μspheres as solid supports for a representative sandwich
fluoroimmunoassay as well as a medium for transport of this assay to the evanescent
sensing surface. Direct detection of bound analyte within the sample mixture is effected
by driving the μspheres to the prism surface, and thus into the evanescent wave (EW),
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using an external magnet. Thanks to the diminutive evanescent field depth, d (~200 nm),
the magnetically delivered analytes can be detected with fewer complications arising
from non-optically homogeneous biological matrices. This means a lower background
(i.e., a higher signal to noise ratio) due to the confinement of the exciting wave to the
prism surface that will contain a monolayer or more of labeled μspheres for TIR
fluorescence (TIRF). The term monolayer is used in discussion of the magnetic particle
assemblies on the prism surface in this chapter, although the particles are separated by
some distance due to inter-structure repulsion. This term is used to differentiate between
a primarily single bead layer and formation of multiple layers or clusters of magnetic
beads on the surface. When referring to a close packed traditional monolayer assembly
in later discussion, the term traditional monolayer is employed.

Because only a

monolayer of μspheres is required for optimum technique performance, the need for and
requisite control of very small well-defined bead beds is circumvented and the magnetic
transport of solid phase reagents is greatly simplified when it entails only the driving of
beads to contact an impenetrable optical interface. What’s more, paramagnetic μspheres
are easily dispersed and recovered in a solution, allowing facile regeneration of the
localized evanescent sensing surface.

This technique eliminates wash steps without

compromising sensitivity, all the while minimizing interference from fluorescing species
present in the bulk sample matrix thanks to a surface-localized evanescent field.
MATEFFs has been optimized by assessing the impact of background interferents
(fluorescein), an optically dense matrix (milk), incident angle, magnetic field direction,
laser power density via focusing and laser power adjustments, and bead concentration.
Utilizing a model sandwich assay system (biotinylated anti-IgG; rabbit IgG; anti-IgG-R74

phycoerythrin), the analytical figures of merit for the technique are evaluated and
reported.

Experimental
Reagents
Sodium dihydrogen phosphate, disodium hydrogen phosphate, Tween 20, bovine
serum albumin (BSA), fluorescein isothiocyanate (FITC), biotin (5-fluorescein),
biotinylated anti-rabbit IgG capture antibody, rabbit IgG, and anti-rabbit IgG-Rphycoerythrin (RPE) were purchased from Sigma-Aldrich (St. Louis, MO) and used as
obtained. FITC and RPE were used in this work as labels because they can be spectrally
distinguished reasonably well and are readily available.

Sodium chloride (NaCl) was

obtained from Mallinckrodt, Inc. (Phillipsburg, NJ) and used as received. Dynabeads®
MyOne™ Streptavidin C1 superparamagnetic µspheres (1 µm diameter) were purchased
from Dynal Biotech (Brown Deer, WI) and diluted using phosphate buffered saline (PBS)
prepared according to Dynal Biotech recommendations. All buffers and solutions were
prepared in deionized, distilled water from a Barnstead 1800 (18 MΩ resistivity).
Apparatus Design
A schematic representation of the MATEFFs instrumental setup is depicted in Figure
4.1. The 488-nm beam from an argon-ion laser (Uniphase Model 2201, San Jose, CA)
was directed through a laser line filter (Edmund Optics, Barrington, NJ) and pinhole
using first surface mirrors (Edmund Optics, Barrington, NJ). The beam was then focused
using a plano-convex lens (Edmund Optics, Barrington, NJ) with either a 125-mm or
175-mm focal length and sent to a beam steering mirror directly mounted
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on a rotary stage for controlling the incident angle of the laser beam on the TIR prism.
To ensure the same spot on the prism surface was illuminated with changing angles, the
vertical position of the rotary stage was controlled via a single axis translational stage.
The TIR prism was an inverted right angle BK7 prism (Edmund Optics, Barrington, NJ)
with n=1.52, surface flatness of λ/4, and surface quality 40-20. By milling flat the angle
opposite the hypotenuse face of the prism, the prism could be placed flush with the
surface of a delrin holder fabricated in-house. The holder contained a sliding block,
which housed a pressure-formed neodymium bar magnet rated at a 10.7 lb. lift
(McMaster-Carr, Atlanta, GA). The block was used to slide the magnet beneath the
prism, as well as remove it when necessary.
A sample compartment was formed from a polydimethylsiloxane (PDMS, Sylgard
184, Dow-Corning, Midland, MI) reservoir, bored using a modified 1.5 mm syringe,
placed directly on the prism surface and enclosed with a glass cover slip. Fluorescence
was collected through a bi-convex F1 lens, passed through a razor-edge 514 nm Raman
filter (Semrock, Rochester, NY), and focused onto a Hamamatsu HC120 photomultiplier
tube-based photosensor module (PMT) (Hamamatsu, Bridgewater, NJ) using another biconvex F1 lens. The fluorescence was additionally filtered before reaching the PMT
using a narrow bandpass interference filter centered at 580 nm (Edmund Optics,
Barrington, NJ) for RPE and 532 nm (Melles Griot, Rochester, NY) for fluorescein. The
output voltage from the PMT was converted at 1Hz by a PMD-1208LS data acquisition
board with TracerDaq® software (Measurement Computing, Middleboro, MA). The
optical photographs shown in Figure 4.1 demonstrate delivery of the magnetic μspheres
to the prism surface, but are not indicative of optimized surface coverage.
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Figure 4.1 Schematic of MATEFFs Apparatus. LLF, laser line filter; PH, pinhole; M,
mirrors; P, prism; L, lens; IF, interference filter; FL, focusing lens;

PMT,

photomultiplier tube; SMH, sliding magnet holder. Optical photos (200 µm x 200 µm)
illustrate surface sequestration of beads. Inset illustrates the bending of light at the
interface between prism and solution and the exponential decay of the evanescent wave.
Refraction (red arrow) occurs at angles smaller than the critical angle, at the critical angle
(green arrow) the light is refracted at 90° along the interface, and total internal reflection
(blue arrow) occurs at angles larger than the critical angle.
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Labeling of µspheres:

In order to perform the optimization tests, Dynal Biotech

Dynabeads MyOne Streptavidin C1 μspheres were fully functionalized, using a sandwich
assay format, with biotinylated anti-rabbit IgG as the capture antibody; rabbit-IgG as the
antigen; and anti-rabbit IgG RPE as the reporter antibody. The μspheres were first
washed with PBS and diluted to 1 mg/mL. A 400 μL aliquot of μspheres was then
removed, separated using an external magnet, resuspended in 400 μL of biotinylated antirabbit IgG (0.05 mg/mL) and allowed to incubate for one hour with gentle rotation.
These µspheres were considered fully biotinylated. The µspheres were then separated,
washed two times with PBS, one time with 0.01% Tween 20 in PBS, resuspended in 400
µL of rabbit-IgG (0.5 mg/mL) and again allowed to incubate for one hour with gentle
rotation. These fully antigen labeled µspheres were again separated, washed as described
previously and resuspended in 400 μL of anti-rabbit IgG RPE (0.1 mg/mL). Lastly, the
µspheres were separated, washed and resuspended in 400 μL of PBS. This fully labeled
μsphere solution was used for all optimization experiments, with 0.6 μL aliquots used to
fill the PDMS reservoir for each individual experiment.
The labeling steps for calibration curve experiments were the same as described above,
except for the concentration of rabbit IgG antigen. After fully biotinylating the μspheres,
they were divided into 50 µL aliquots and labeled using rabbit IgG standards ranging in
concentration from 20 to 200,000 μg/L, followed by full labeling as previously described.
For multi-analyte experiments, the DynaBead μspheres were directly labeled with biotin5-fluorescein (6000 pmol) by incubating for one hour with gentle rotation.
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Results and Discussion
In this work, functionalized magnetic µspheres are driven into contact with the surface
of a prism, where an evanescent wave has been generated via total internal reflection,
using a strong external magnet on the underside of the prism.

To our knowledge, this

represents the first attempt to use magnetic transport of a fluoroimmunoassay to a
localized field for EW excitation.

Consequently, experimental conditions for the

MATEFFs technique require optimization.
Evanescent wave penetration depths are dependent upon the wavelength of the laser,
the incident angle, and the refractive indices of the liquid and solid. At the critical angle,
light traveling from the high refractive index medium (prism) to the low refractive index
medium (solution) will be refracted at 90° along the interface. At any angle larger than
the critical angle, the light is totally internally reflected except for the EW generated at
the prism surface. The penetration depth of the EW increases as the incident angle
approaches the critical angle as given below
d=

λ
4π n12 sin 2 θ − n 22

(4-1)

where λ is the laser wavelength, θ is the incident angle, and n1 and n2 are the refractive
indices of the prism and solution, respectively.
In this work, penetration depth is changed by incrementally varying the angle on the
mirror steering the incident beam. Initially, the formation of the EW was confirmed by
magnetically transporting RPE functionalized μspheres to the prism surface and scanning
through incident angles using the beam-steering mirror until a marked increase in
fluorescence signal resulted from refraction of the laser light into the bulk solution. The
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merit of MATEFFs as a method of delivery to a localized field in the presence of a
complex matrix was then established by preparing the RPE functionalized μsphere
solution in a background matrix containing 1 µM fluorescein as a model interferent.
Figure 4.2 compares the emission of RPE and fluorescein (emission bandpass filters
centered at 580 nm [10 nm FWHM; 67% transmission] and 532 nm [10 nm FWHM; 45%
transmission], respectively) as a magnet is used to deliver the μspheres to the EW.
Because the broad fluorescence emission of fluorescein overlaps with that of RPE,
corrections were made to the 580 nm emission data in order to eliminate the signal
contribution from fluorescein, which was determined to be 13% of the fluorescein
emission at 532 nm. In addition, a small amount of autofluorescence from the μspheres
themselves is present at 532 nm and that emission is corrected by subtracting the value of
autofluorescence determined from the solution of RPE alone. Starting at an incident
angle of ~63° and approaching the critical angle (~61°, CA in the figure) the RPE
fluorescence intensity increases as more molecules are excited by the deeper penetrating
EW. The change in fluorescence emission as the incident angle is approached follows
the shape of the calculated curve for the change in EW penetration depth with incident
angle change as expected (Figure 4.2 inset). Once the incident angle falls below the
critical angle, refraction of the laser beam into the bulk solution causes the fluorescence
intensity of both RPE and fluorescein to dramatically increase (grey and black bars off
scale in Figure 4.2) due to excitation of fluorophore in the bulk solution. This experiment
was repeated and similar angle-fluorescence trends were observed. The signal resulting
from excitation of μsphere immobilized RPE is significantly diminished at the optimum
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Figure 4.2 Comparison of fluorescence emission from fully functionalized RPE µspheres
in a 1 µM fluorescein solution in the presence and absence of an external magnet field at
different incident angles. RPE µsphere emission with magnet (grey bars); RPE µsphere
emission without magnet (red bar); 1 µM fluorescein emission without magnetically
delivered µspheres (black bars); 1 µM fluorescein emission with magnetically delivered
µspheres (blue bars). The arrow demonstrates the difference between signals when the
magnetically labeled beads are delivered to the localized field with an external magnet as
compared to no magnetic delivery. The insert demonstrates the change in penetration
depth with incident angle calculated from Equation 4-1
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incident angle upon removal of the external magnet (~1/90th the signal with magnetic
delivery; red bar) due to transport of the beads away from the interface and out of the
most intense portion of the EW. In addition, fluorescein emission is reduced upon
magnetic delivery of the μspheres to the evanescent field due to displacement of matrix
volume by the μspheres.
These results serve as a preliminary demonstration of the ability of MATEFFs to
reduce complications arising from spectral matrix interferences. All further experiments
were performed at an incident angle ~0.5º above the critical angle. To further illustrate
the MATEFFs advantage when dealing with an optically dense medium, milk was used
as an opaque matrix (Figure 4.3). The detection of fully RPE functionalized magnetic
μspheres was realized using the MATEFFs technique in two different milk matrices and
compared to fluorescence detection of rhodamine 6G in the same matrices using a
simulated homogeneous assay. The signal from R6G in 1:1 milk:PBS matrix using the
simulated homogeneous assay was less than 8% of the signal from R6G in PBS alone.
Conversely, using the MATEFFs method, the fluorescence signal from immobilized RPE
in the same milk matrix was nearly 65% that of the signal from RPE in PBS alone
Optically dense matrices in conventional immunoassays create problems by significatntly
reducing response intensity, thereby necessitating multiple wash steps to get rid of
interfering effects. In MATEFFs, there is only moderate reduction in response intensity
in the presence of a very optically dense matrix (1:1 milk:PBS), due to passage of the
emission through approximately 1.5 mm of matrix (see Figure 4.1), and the analyte of
interest can be detected in the presence of fluorescent interferents because of selective
target delivery to the highly localized evanescent field without call for multiple wash
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steps.
It is important that μsphere coverage on the prism surface be maximized, as relevant
analyte is transported to the EW by the μspheres. Superparamagnetic particles, when
placed in a magnetic field, will acquire a magnetic moment and interact by way of
magnetic dipole forces.86 Because of these dipole forces, the particles will begin to
cluster into large, column-like structures often called supraparticle structures (SPS),
which align in the direction of the magnetic field. For this reason, the effect of magnetic
field direction on the resulting fluorescence signal from the model sandwich assay system
was probed. Micrographs taken in the lab (Figure 4.4) reveal that perpendicular magnetic
fields, created by a bar magnet with field lines approximately perpendicular to the prism
surface, cause the SPS to align vertically and grow larger in the vertical direction with
increasing bead concentration. In contrast, a magnetic field created by a bar magnet with
field lines approximately parallel to the prism surface leads to SPS that form horizontally
along the prism surface. These micrographs are not indicative of optimized prism surface
coverage, as they only serve to make a distinction between the parallel and perpendicular
magnetic fields. As evidenced in Figure 4.4, a magnetic field that is parallel to the
surface of the prism yields a greater fluorescent signal at every incident angle tested in
comparison to a magnetic field perpendicular to the prism surface. Although the parallel
magnet orientation proved to be important in maximizing fluorescent signal, presumably
due to an increase in the amount of functionalized μspheres in contact with the prism
surface with a parallel magnetic field, perfect parallel field alignment was not critical as
slight tilting of the bar magnet to manipulate SPS surface placement exhibited no
improvement in observed signal.
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Figure 4.4 The orientation of the magnetic field with respect to the prism surface
(parallel (black bars) or perpendicular (blue bars)) has a marked effect on fluorescent
signal. Once past the critical angle, fluorescence signal from both magnetic fields is off
scale due to refraction of the laser light into the bulk solution. Optical photos (200µm x
200µm) illustrate the direction of supraparticle structure growth.
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The effect of increasing laser power on the ability of the EW to excite bead-bound
fluorophores was also investigated. The goal is to evanescently excite the maximum
number of fluorophores while avoiding any deleterious effects, such as photobleaching,
bond degradation, or thermally induced migration away from the EW. In addition to
varying power over the range available with our laser, we used two lenses with different
focal lengths; 125 mm that produced a smaller focused diameter of ~77 μm and 175 mm
that produced a larger focused diameter of ~108 μm.98

The plots shown in Figure 4.5

demonstrate an expected behavior. Signals increase rapidly with increasing power at low
powers but show evidence of the aforementioned deleterious effects at higher powers as
seen by leveling-off of the plots. The longer focal length lens probes roughly a factor of
two greater surface area than the short focal length lens. The bottom two data points for
each of the two lenses (each curve) happen to be at equivalent power densities incident
on the prism surface (~ 30 W/cm2) and show almost a factor of two greater signal for the
long focal length lens, correlating well with greater probed surface area. Although the
larger probe area is desirable in terms of raw signal, it does require larger confinement
vessels or channels and more beads.
As a final optimization study, different concentrations of functionalized μspheres were
utilized in an effort to achieve the most uniform surface coverage. When using one
micron diameter μspheres, the evanescent wave (~200 nm) cannot fully probe the entire
μsphere, thereby necessitating only a monolayer of beads on the prism surface. Although
it is important to maximize surface coverage, any excess bead formation (multilayers or
would not be excited by the EW and would serve only to interfere with signal collection.
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Figure 4.5 Assessment of the relationship between laser power and fluorescence signal using
two lenses with different focal length. The larger focal length 175 mm lens (red diamonds)
probes a greater surface area than the 125 mm lens (black squares).
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clustering) on the prism surface may hinder TIRF signal collection, as these multilayers
This is evidenced in Table 4.1, which displays fluorescence signals measured and relative
standard deviation (RSD) values calculated (n = 4) for six concentrations of
functionalized magnetic μspheres. As μsphere concentration increases, the fluorescence
signal increases and then begins to decrease at the highest measured concentration.
Additionally, the RSD values decrease and again increase with the concentration of
μspheres. A μsphere concentration of 0.6 µg was selected for use in construction of the
calibration curve due to the desire to conserve sample while maintaining acceptable
signal and RSD values.
The linear dynamic range and detection limits of this immunoassay technique were
evaluated by constructing a calibration curve (Fig 4.6). Standard solutions of rabbit IgG
ranging in concentration from 20-20,000 ng/mL were tested using the MATEFFs
technique. A quite respectable linear dynamic range (y(V) = 0.0007x (ng/mL) + 0.111) of
nearly three orders of magnitude is established (R2=0.991) with a detection limit of 42
ng/mL (~280 pM) for this particular assay. Error bars for the calibration curve were
assigned based on the RSD values defined in Table 4.1 for 0.6 µg bead concentration.
Table 4.1 RSD values (n=4) and fluorescence signals for 6 µsphere concentrations.
Bead Concentration (µg)

Fluorescence Signal (V)

RSD Value (%)

0.15

1.32

7.8

0.30

1.98

6.8

0.45

2.06

3.1

0.60

2.70

5.0

0.75

3.76

7.9

0.90

3.34

7.6
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Figure 4.6 Calibration Curve for Rabbit IgG with R2=0.991 and detection limit of 42
ng/mL.
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In order to demonstrate the compatibility of MATEFFs with multi-analyte systems,
μspheres fully labeled with RPE and fluorescein were employed. Simultaneous detection
was achieved by using the two narrow band interference filters, centered at 532 nm for
fluorescein (Melles Griot, Rochester, NY) and 580 nm
Barrington, NJ), interchangeably.

for RPE (Edmund Optics,

As mentioned in the discussion for Figure 4.2,

corrections were made to the data to adjust for autofluorescence from the μspheres
themselves at 532 nm, as well as the overlap of fluorescein emission with that of RPE at
580 nm. Comparison of fluorescence emission from solutions of RPE labeled beads,
fluorescein labeled beads and mixtures of the two at different ratios were measured using
the MATEFFs technique (Figure 4.7).

There is a clear trend shown between the

fluorescence emission from the two analytes and the changing ratios of the mixtures.
Though not quantitated, this illustrates that the MATEFFS technique is amenable to
measurement of multiple analytes in one sample mixture by employing spectrally distinct
fluorophores and interchanging emission filters.
Conventional heterogeneous immunoassays performed in microtiter wells are
diffusion limited, as the antigen/antibody must migrate to the surface of the well to
interact with an immobilized antigen/antibody, resulting in reaction solid surface area to
solution volume ratios (S/V) on the order of 10 cm-1.

A recent report cleverly

incorporated polystyrene bead solid supports into a glass microchannel using a capture
dam and reported a S/V of 480 cm-1.99 This improvement in S/V essentially meant a
larger reaction field and the reaction rate was made 90 times faster compared to a similar
conventional microtiter plate immunoassay due to a decrease in diffusional distances
between antibody and immobilized antigen. The work of Hayes et al. took this concept
90

Fluorescence (V)

100

Fluorescence (V)

5

80
60

Fluorescein

40
20
0
400

4

RPE

440

480

520

560

600

640

680

Wavelength (nm)

3
2
1
0

0:1

1:4

1:1

4:1

1:0

Ratio of Fluorescein to RPE

Figure 4.7 Multi-analye experimental data. RPE emission is monitored via a 580 nm
bandpass filter (red bars) and fluorescein emission is monitored via a 532 nm bandpass
filter (blue bars). The inset illustrates emission for each fluorophore collected by their
respective bandpass filter (greyed areas on emission spectra).
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even further by using an orthogonal magnetic field to hold stationary a plug of magnetic
beads in a microchannel. This flow based microimmunoassay resulted in a S/V of 1.3 x
104 cm-1 within the detection volume, defined by the specific area quantitated within a
fluorescence micrograph.94 Within the current detection volume for MATEFFs, the
evanescent wave volume, the S/V is 4.0 x 104 cm-1. However, MATEFFs is not a
classical heterogeneous immunoassay. A unique advantage of the MATEFFs technique
is that µsphere labeling occurs in free solution without any type of µsphere sequestration
(weirs, membranes, applied magnetic fields, etc) followed by delivery of the labeled
µspheres from within the bulk solution to a localized evanescent sensing surface for
detection. MATEFFs are not volume limited because the µspheres are able to fully
interact with the analyte-containing sample before delivery to the detection zone for EW
probing. Since it is only necessary to deliver a monolayer of µspheres to the evanescent
sensing surface, the concentration of magnetic µspheres employed is adjusted
accordingly and the entire µsphere constituent is interrogated via the EW. By
concentrating the µsphere volume at the sensing surface, much free solution (or matrix)
volume is displaced. This fact, combined with the localized EW, serves to reduce
background interference from the bulk medium. It is, therefore, important to illuminate
the largest possible µsphere surface area, in order to boost analyte density in the EW,
while limiting the free solution volume within the EW interrogated region. It is clear
from calculation (Table 4.2) that, for a given area of EW illumination, matching EW
penetration depth to the diameter of the µsphere creates an ideal situation whereby
µsphere surface area interrogated by the EW is maximized and free solution volume is
minimized. For ease of comparison, the calculations from Table 4.2 were based on the
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Table 4.2 Calculations for Optimized Analyte Density. Optimization of analyte density
within EW assuming a traditional monolayer µsphere surface coverage within a 10 μm X
10 μm  square illuminated by the given evanescent wave depth. In order to perform the
calculations for this data, equations for the surface area and volume of a spherical cap
were used to approximate bead surface area and volume. Additionally, the EW volume
was calculated assuming a square with dimensions stated above.
Evanescent Wave Depth (d)
100 nm

200 nm

Bead Size (nm)

Surface Area
Probed (μm2)

Free Solution
Volume (%)

Surface Area
Probed (μm2)

Free Solution
Volume (%)

100

314

48

314

74

500

63

73

127

54

1,000

31

85

63

73
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assumption of traditional close packed monolayer coverage for each bead size on the
prism surface. It should be noted that as the bead density increases the interfacial optical
properties of the system may also change. The high specific interface of the MATEFFs
technique directly relates to the minimization of interference from complicated, nonoptically homogeneous matrices. The amount of matrix present in the detection volume,
free solution volume, decreases as the specific interface is increased. By optimizing
conditions, as shown in Table 4.2, the specific interface could be increased to 4.0 x 105
cm-1 while lowering detection limits and minimizing reagent consumption.
The following chapter will discuss ongoing MATEFFs studies taking advantage of a
microfluidic device for multiplexing and passive sample delivery to a localized
evanescent sensing surface.

Planar waveguide technology is explored for efficient

surface-confined excitation of magnetically delivered analyte within the evanescent field
created by waveguide light propagation.

94

CHAPTER 5.
MULTIPLEXED, WAVEGUIDE APPROACH TO MAGNETICALLY
ASSISTED TRANSPORT EVANESCENT FIELD FLUORO-ASSAYS
Introduction
Bioaffinity systems, encompassing such techniques as immunoassay and
oligonucleotide hybridization, are routinely used in clinical, environmental and
genetic analyses.60, 87, 100, 101 It is important, when dealing with these systems, that
sample and time are conserved while preserving sensitivity and specificity.
Moreover, simultaneous parallel analysis of several analytes or samples is desirable.
Addressing these needs, microfluidic separation and fluid handling systems have
garnered much attention in the past decade as a portable, small footprint means of
carrying out chemical and biological processes on a manageable, solvent- and sampleconserving platform.89

The current work integrates microfluidic and planar

waveguide technology for simultaneous investigation of multiple bioaffinity systems
using judicious sequestration of target analyte on magnetically controlled beads,
thereby facilitating delivery of the target from within a bulk mixture to a localized
evanescent field sensing surface inside a microfluidic platform. To our knowledge,
this represents the seminal report of selective magnetic transport of analyte to a
localized evanescent field present on the surface of a simple and versatile integrated
microfluidic/waveguide device.
Magnetic microspheres (µspheres) have found utility as solid phases for
biomolecule immobilization. In general, µspheres possess a large specific surface for
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binding, mobility of the solid phase, and an attendant enhancement in interaction of
the phase surface with passing fluids.

Furthermore, magnetic µspheres permit

manipulation independent of fluidic flow, making possible the delivery of
immobilized analytes, be they proteins or small molecules, to a specific zone.
Magnetic µspheres are amenable to miniaturization and multiplexing using different
capture probes.

This work expands upon the recently developed magnetically-

assisted transport evanescent field fluoro-assay (MATEFFs), a novel technique
combining the advantages of both the homogenous and heterogeneous assay while
eliminating some of the drawbacks, as discussed in the previous chapter.102
MATEFFs sought to reconcile the advantages of solid support sample concentration
with the need to eliminate complicated separation steps by, for the first time,
combining selective magnetic transport of analyte to a highly localized evanescent
electromagnetic field. In this work, the electromagnetic field is created using a planar
waveguide to direct excitation light.
Planar waveguide technology makes use of the process of total internal reflectance
at an optical interface.

The concept of TIR, having previously been discussed,

basically entails the total reflection of light at an interface under ideal conditons
except for an exponentially decaying, localized evanescent field. The evanescent
field, in the present work, is created at the surface of a standard microscope slide
used as a type of bulk, planar waveguide with propagation of incident light by way of
multiple internal reflections. The implementation of a microscope slide is attractive
due to the low cost and ease of waveguide development, as compared to other planar
waveguide systems.80 The process of waveguide excitation was achieved using a
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cylindrical lens to focus collimated laser light on the edge of the waveguide,
providing a uniform evanescent sensing surface after a couple of non-collimated
reflections, as previously described.82 The cylindrical lens results in divergence only
in the direction of beam propagation, enhancing uniformity while maintaining good
photon density.
The two dimensional microscope slide structure allows for construction of
multichannel microfluidic architecture on the waveguide surface.

A PDMS

microfluidic device, conformally sealed to the slide surface, makes possible
simultaneous interrogation of six analyte samples in separate channels.

Labeled

magnetic beads are passively pumped, using a previously published method, through
microfluidic channels and sequestered within the evanescent wave at the microscope
slide surface using an external magnet.103 The passive pumping method utilizes the
surface energy of a droplet placed in the microchannel reservoir to pump liquid
through the channel. The only equipment required for this pumping method is a
pipette, making it simple, effectual and semi-autonomous. A controlled quantity of
magnetic beads can be efficiently pumped through each microchannel and delivered
to the waveguide surface using an appropriately placed external magnet. Thanks to
the diminutive evanescent field depth, the magnetically delivered analytes can be
detected with fewer complications arising from nonoptically homogeneous biological
matrices. Facile regeneration of the evanescent sensing surface is possible, as a result
of the ease with which paramagnetic beads are dispersed and recovered in a solution,
by simply removing the external magnet. The current technique was optimized using
a sandwich immunoassay for IgG to determine appropriate experimental conditions.
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Analytical figures of merit are reported for this technique using IgG and IL-4
sandwich immunoassays. Additionally, the potential applicability of this technique to
a DNA hybridization study is explored.

Experimental
Reagents
Sodium dihydrogen phosphate, disodium hydrogen phosphate, Tris-HCl, EDTA,
ethidium bromide, Tween 20, bovine serum albumin (BSA), fluorescein, biotinylated
anti-rabbit IgG capture antibody, rabbit IgG, and anti-rabbit IgG-R-phycoerythrin
(RPE) were purchased from Sigma-Aldrich (St. Louis, MO) and used as obtained.
Biotin anti-human interleukin-4 (IL-4), recombinant human IL-4, and phycoerythrin
(PE) anti-human IL-4 were purchased from Ebiosciences (San Diego, CA) and used
as received. All custom DNA primers (including a biotinylated 100mer strand, the
100mer complement, and a 100mer non-complement) were purchased in lyophilized
form from Invitrogen Corporation (Carlsbad, CA) and reconstituted according to
Invitrogen

recommendations.

Sodium

chloride

(NaCl)

was

obtained

from

Mallinckrodt, Inc. (Phillipsburg, NJ) and used as received. Dynabeads® MyOne™
Streptavidin C1 superparamagnetic µspheres (1 µm diameter) were purchased from
Dynal Biotech (Brown Deer, WI) and diluted using phosphate buffered saline (PBS)
prepared according to Dynal Biotech recommendations. All buffers and solutions
were prepared in deionized, distilled water from a Barnstead 1800 purification system
(18 MΩ resistivity).
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Apparatus Design
A schematic of the instrumental setup is depicted in Figure 5.1. For immunoassay
work, the 488-nm beam from an argon-ion laser (Uniphase Model 2201, San Jose,
CA) was directed through a laser line filter (Edmund Optics, Barrington, NJ) and
pinhole using first surface mirrors (Edmund Optics, Barrington, NJ). The beam was
then sent to a beam steering mirror directly mounted on a rotary stage for controlling
the incident angle of the laser beam on the microscope slide (waveguide). To ensure
the same spot on the waveguide was illuminated with changing angles, the vertical
position of the rotary stage was controlled via a single axis translational stage. The
incident beam was passed through a cylindrical lens (Edmund Optics, Barrington, NJ)
before reaching the waveguide edge. The waveguide was positioned using a delrin
holder fabricated in-house. The holder contained a sliding block, which housed a
pressure-formed neodymium bar magnet rated at 10.7 lb lift (McMaster-Carr, Atlanta,
GA). The block was used to slide the magnet beneath the waveguide and remove it
when necessary.

Additionally, the holder included a side mounted, motorized

translational stage with an attached cage system housing all collection optics.
Fluorescence was collected through a biconvex F1 lens, passed through a razor edge
514 nm Raman filter (Semrock, Rochester, NY), and focused onto a Hamamatsu
HC120 photomultiplier tube (PMT) (Hamamatsu, Bridgewater, NJ) using another
biconvex F1 lens. Fluorescence was additionally filtered before reaching the PMT
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filters and lenses
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Stage
Microfluidic
Cylindrical Lens

Waveguide

Figure 5.1

Magnet

Schematic of experimental apparatus.

The cage unit is translated via

motorized translational stage while the waveguide, PDMS microfluidic and magnet
remain fixed.
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using a longpass filter with cut-off position at 610 nm (Edmund Optics, Barrington,
NJ) for RPE detection and a narrow bandpass interference filter centered at 532 nm
(Melles Griot, Rochester, NY) for detection of fluorescein.

DNA hybridization

studies employed virtually the same optical set-up with the exception of the use of a
portable 50 mW, 532 nm laser for ethidium bromide excitation (OnPoint Lasers,
Minneapolis, MN). Output voltage from the PMT was converted at 1 Hz by a PMD1208LS data acquisition board with TracerDaq software (Measurement Computing,
Middleboro, MA). The entire cage system could be scanned a total of 12 mm at up to
425 µm/sec across the surface of the waveguide and could, thus, interrogate six
microfluidic channels.
The six channel microfluidic platform was fabricated from PDMS (Sylgard 184,
Dow-Corning, Midland, MI) using a previously published procedure with the
exception of the use of a transparency in place of an aluminum photomask.104

The

six channels were approximately 450 μm wide, 200 μm deep, and 4.5 cm long. A
passive solution pumping method was employed for filling that simply involved
adjusting the fluid levels at the channel terminating reservoirs.103 The magnet was
positioned at the approximate channel midpoint.
Labeling of µspheres.
IgG. In order to perform the optimization tests, Dynal Biotech Dynabeads MyOne
Streptavidin C1 µspheres were fully functionalized, using a sandwich assay format, with
biotinylated anti-rabbit IgG as the capture antibody; rabbit-IgG as the antigen; and antirabbit IgG RPE as the reporter antibody. The µspheres were first washed with PBS and
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diluted to 1 mg/mL. A 400 μL aliquot of µspheres was then removed, separated using an
external magnet, resuspended in 400 μL of biotinylated anti-rabbit IgG (0.05 mg/mL) and
allowed to incubate for one hour with gentle rotation. These µspheres were considered
fully biotinylated. The µspheres were then separated, washed two times with PBS, one
time with 0.01% Tween 20 in PBS, resuspended in 400 μL of rabbit-IgG (0.5 mg/mL)
and again allowed to incubate for one hour with gentle rotation. These fully antigen
labeled µspheres were again separated, washed as described previously and resuspended
in 400 μL of anti-rabbit IgG RPE (0.05 mg/mL). Lastly, the µspheres were separated,
washed and resuspended in 400 μL of PBS. This fully labeled µsphere solution was used
for all optimization experiments. Labeling steps for generation of a calibration curve
were basically the same as described above, except for the concentration of rabbit IgG
antigen. After dividing into 50 µL aliquots, rabbit IgG standards ranging in concentration
from 20 to 200,000 ng/mL were used, followed by full labeling with the reporter
antibody.
IL-4. For IL-4 studies, 500 µL of pre-washed Dynal µspheres (1 mg/mL) were
separated using an external magnet, washed and resuspended for a 30 minute
incubation with rotation in 500 µL of biotin anti-human interleukin-4 (0.05 mg/mL).
These beads were then washed as previously described and resuspended in the same
volume. Aliquots were removed (50 µL) and diluted to 100 µL for incubation with
appropriate concentrations of interleukin-4 antigen followed by labeling with
phycoerythrin anti-human IL-4 (.025 mg/mL).
DNA. Following the protocol from Dynal Biotech for biotinylated oligonucleotide
labeling, the µspheres were first washed and resuspended in a 2x Binding & Washing
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(B&W) buffer at a concentration of 1 mg/mL. To this solution was added an equal
volume of TE buffer containing 50 pmol of biotinylated DNA. This mixture was
incubated with rotation for 15 minutes followed by three wash steps with 1x B&W.
The µspheres are then resuspended in 100 µL of either complement or noncomplement DNA (50 pmol) and incubated for 15 minutes, followed by wash steps.
The dsDNA complex was then resuspended in 5 µM ethidium bromide for subsequent
fluorescence detection.

Results and Discussion
In order to fully exploit the advantages of our previously reported MATEFFs
technique, this work integrates planar waveguide and microfluidic technology. This
is, to our knowledge, the first report detailing magnetic transport of a bioaffinity
system to a localized evanescent field created on a waveguide surface using
microfluidic sample delivery.

The application of microfluidics to the field of

heterogeneous immunoassay is attractive due to consequent improvement in assay
kinetics, reagent and time consumption, waste production and the possibilities for
automation.105,
research.
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Evanescent wave detection has long been used in immunoassay

Some work in the area of bioaffinity reaction monitoring using

both

microfluidics and evanescent wave detection has been reported, but requires
immobilization procedures for the capture element on the transducer surface and
employs complicated fluidic systems.80,

107

In the present work, experimental

conditions were first optimized using a model sandwich immunoassay system for IgG.
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The occurrence of total internal reflection (TIR), confining excitation light traveling
through the waveguide, depends upon laser wavelength, incident angle, and refractive
indices of the waveguide and surrounding medium. It is important to establish a set
of conditions that maximizes depth of EW penetration into the sample channels, and
thus evanescent field strength, when using the EW to probe molecules at the interface.
In this work, penetration depth is changed by incrementally varying the angle on the
mirror steering the incident beam.

Evanescent wave formation was initially

confirmed by magnetically transporting RPE functionalized μspheres to the
waveguide surface and scanning through incident angles using the beam-steering
mirror.

Figure 5.2 illustrates the change in fluorescence emission from the

magnetically delivered RPE labeled beads with change in incident angle (approaching
the critical angle). The fluorescence signal increases in all six microfluidic channels
until an incident angle of ~71º is reached.

The signal then begins to decrease,

presumably due to inefficient coupling of light into the waveguide once conditions for
TIR are no longer satisfied.

PDMS (n ≅ 1.47) was the waveguide surrounding

medium, as the microfluidic platform was constructed from PDMS, and the critical
angle for PDMS:glass was calculated to be ~75º. However, the optimal angle needed
to be determined experimentally as the use of the cylindrical lens causes a distribution
of angles impinging on the interface. Additonally, the refractive index for PDMS
could vary depending on the curing temperature employed during the fabrication
process. Additional experiments were performed for optimization of laser power and
bead plug concentration. It was determined that the optimal concentration of beads
used in formation of a plug was 0.5 µg and a plot of fluorescence emission versus
104
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Figure 5.2 Fluorescence emission from RPE labelled magnetic µspheres in each of six
microfluidic channels with change in incident angle (approaching critical angle).
Channel 1 is the first channel interrogated in the direction of waveguide excitation.
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laser power linearly increased from 1.5 to 12 mW (data not shown).

Further

experiments were performed using a 0.5 µg bead plug and ~10mW laser power
A benefit of evanescent wave detection is the localization of the electromagnetic
field to the waveguide surface. In this case, the analytes are delivered to this surface
and, even in the presence of background interferents, can be detected without call for
multiple wash steps. This fact is evidenced in Figure 5.3, where a 1 µM solution of
fluorescein was used as model interferent. Figure 5.3A measures the signal at 532
nm, which originates primarily from background fluorescein (blue bars).

When

magnetic beads are added to the fluorescein solution and a field transported plug is
formed, the fluorescein signal sharply decreases due to the displacement of matrix
volume in the evanescent field by the µspheres (black bars). Additionally, Figure
5.3B depicts the signal measured by the longpass filter with a cut-off position at 610
nm, which results from bead immobilized RPE (red bars). This signal in the presence
of 1 µM fluorescein is only slightly decreased, presumably due to absorbance of some
evanescent radiation by fluorescein present at the waveguide surface (black bars).
Therefore, fluorescence measurements for the analyte of interest can be accomplished
in the presence of background matrix, and bead delivery actually aids in matrix
displacement from the EW.
As laser light travels through the waveguide, it naturally decays as a result of
waveguide losses, such as absorbance or scattering. This is evidenced in Figure 5.2
by the fact that the signal decreases as the EW propagates longitudinally from channel
1 to 6. In order to correct for the natural abatement of signal across the waveguide, an
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Figure 5.3 Determination of matrix interference effects using RPE labelled magnetic
beads with 1 µM fluorescein as background matrix.

A) Fluorescence emission of

fluorescein measured at 532 nm with (black bars) and without (blue bars) magnetic
beads. B) Fluorescence emission of RPE measured at 580 nm with (black bars) and
without (red bars) fluorescein.
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experiment was performed

whereby change in signal from a 1 µM fluorescein

solution was measured across the six channels and used to normalize data.

The

normalization plot (Figure 5.4) exhibited a ~6% decrease/channel in signal from
channel 1 to 6.
The linear dynamic range and detection limits of this immunoassay technique were
evaluated by constructing a calibration curve for detection of rabbit IgG. Standard
solutions of rabbit IgG ranging in concentration from 20 to 20,000 ng/mL were tested.
As shown in Figure 5.5, a quite respectable linear dynamic range (y(V) = 0.0005x
(mg/mL) + 1.156) of nearly 3 orders of magnitude is established (R2=0.997) with a
limit of detection of ~120 ng/mL (800 pM).
To demonstrate selectivity, a sandwich immunoassay for the detection of
interleukin-4 (IL-4), a cytokine which promotes proliferation and differentiation of B
cells, was employed.

IL-4 was detected with an RSD of 5% at four different

concentrations. IgG was used as a model cross reactant to test specificity of the IL-4
sandwich immunoassay. The fluorescence emission for 700 ng/mL IgG was less than
2% that of an equivalent concentration of IL-4 (Figure 5.6). Additionally, using the
four measured concentrations of IL-4 to generate a best fit line, a detection limit of 10
ng/mL was established (R2=0.999).
In order for miniaturized assay systems to compete with accepted macroscopic
techniques in terms of sensitivity, the detectable signal must be maximized along with
minimization of background.

Since, in sandwich immunoassays, only those analyte

molecules bound to capture antibody will generate a signal upon binding of the
reporter antibody, it is important to maximize binding. Although always governed by
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Figure 5.4 Normalization plot illustrating decrease in emission from the six channels as
light propagates longitudinally across the waveguide
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Figure 5.5 Calibration curve using a sandwich immunoassay for detection of IgG. The
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Figure 5.6 Calibration data for interleukin-4 . Four different concentrations of IL-4 were
measured and are shown.

The inset illustrates the best fit line for these four

measurements. Using this data, an RSD of 5% was calculated with a detection limit for
IL-4 of 10 ng/mL. Additionally, the signal from IgG as a model cross reactant was
measured.
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the affinity binding equilibrium, sandwich immunoassays have been classified as
either “ambient analyte” or “mass-sensing” assays based upon how analyte
concentration in solution is changed upon binding to capture antibody.72 For an
ambient analyte assay, a small amount (e.g., <1.5%) of the total analyte concentration
is bound to capture antibody, whereas a mass sensing assay could result in near
complete depletion of antigen from a sample solution (~ 100% bound). This means
that for a given concentration of analyte solution, the measured signal from an
ambient analye assay will not change with changes in assay volume. Conversely, a
mass sensing assay will yield a signal proportional to the actual amount (mass) of
analyte present in solution.108
It follows, then, that analyte harvesting by a mass sensing assay would decrease
detection limits by permitting detection of practically all analyte molecules present in
a given sample. The ability of a given assay to exhibit mass sensing characteristics is
attributed to a capture antibody concentration greater than 0.01/Ka (where Ka is the
affinity constant) and/or high Ka values.

If higher affinity antibodies are not

available, then the density of capture antibody in a given area must be increased in
order to improve sensitivity.

This is a difficult task, since high density arrays

normally require sophisticated and expensive printing processes. However, using the
technique described herein, we illustrate mass sensing behavior that also has the
inherent advantage of efficient magnetic bead mixing with the sample. Furthermore,
the “concentrated” bound analyte can then be delivered to a localized field for
detection in a miniaturized volume. To demonstrate the ability of the technique to
perform mass sensing, a sample of IL-4 at a concentration of 700 ng/mL was divided
112

into four aliquots, with three of the aliquots diluted to concentrations of 350, 233, and
140 ng/mL by incrementally increasing the sample volume. The actual analyte mass
stayed the same in all samples, although the concentration decreased. Each analyte
sample was then used to label the magnetic beads and fluorescence emission was
measured as previously described.

The fluorescence measurements from each of

these samples resulted in an RSD of only 12% (data not shown). This is significant
because it demonstrates that changes in the effective concentration of the analyte
solution (up to a 5x dilution) did not result in a proportional decrease in signal. This
is because the signal reflected the amount of analyte present, or actual mass of
analyte. Based on these results, this method appears to operate as a mass sensing
assay with actual harvesting of all analyte present in the sample. The incubation
times for all samples were the same, although the solution volumes were different.
The RSD value may have been lowered by increasing incubation time for larger
volume samples to ensure complete mixing. Consequently, the actual concentration
detection limits stated for the IL-4 assay could be made significantly lower by
increasing sample volume. It is especially significant that the magnetic beads act as
analyte harvesters as they are the ultimate means of analyte delivery to the localized
detection zone and, moreover, decrease background interference due to the matrix
volume displacement upon magnetic delivery.
As a final example of versatility, the technique was applied to detection of DNA
hybridization via fluorescence emission from ethidium bromide intercalator. While,
in genetic studies, it is currently important to apply high density oligonucleotide
arrays to gene expression monitoring, there is also a need for methods to rapidly
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analyze samples based on a specific question related to such issues as disease
diagnosis and susceptibility, or drug discovery.107-109 The work reported herein is a
preliminary step seeking to demonstrate the potential of this method in such specific
analysis. A single stranded DNA 100mer was immobilized on the magnetic bead,
followed by incubation with either a complementary or non-complementary strand in
the presence of ethidium bromide (EB). EB, upon intercalation into the DNA double
helix, undergoes a fluorescence enhancement.

Therefore, successful DNA

hybridization should be detectable via measurable increase in EB fluorescence
emission as compared to EB background from running buffer.110

Figure 5.7 depicts

the results for the comparison of DNA with complement compared to noncomplement hybridization in the presence of EB running buffer. The signal from
complement hybridization was nearly 300% greater than that for non-complement
after EB background subtraction.

This suggests that the technique could find

application in genetic analyses. The system described herein is non-ideal due to
possible electrostatic interaction of EB with ssDNA and regions of homo-duplex
formation in the ssDNA 100mer sequences. Addressing these issues, with the use of
a better intercalator that is more specific for dsDNA and/or shorter DNA sequences,
could

improve

discrimination

between

complement

and

non-complement.

Additionally, conditions such as temperature, salt concentration, and ssDNa binding
density could be investigated and optimized. Upon completion of these steps, the
presence of a specific disease-related sequence upon hybridization to its complement
or the interaction of a drug with a hybridized DNA-EB complex could be detected
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Figure 5.7 Comparison of fluorescence emission for complement vs. non-complement
DNA hybridization in the presence of 5 µM ethidium bromide running buffer.
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via changes in EB fluorescence using this simple lab-on-a-chip platform without need
for pre-labeling steps or expensive instrumentation and complicated data analysis
required for the use of current DNA microarrays.

Conclusions and Future Work
This work represents the integration of microfluidic and planar waveguide
technology for simultaneous investigation of multiple bioaffinity systems. A simple
PDMS microfluidic platform is employed for delivery of magnetic bead containing
solution using a passive pumping technique which circumvents the need for
sophisticated and expensive external equipment. Furthermore, the waveguide is a
basic microscope slide which provides a planar surface for microfluidic attachement
and efficiently propagates the EW uniformly across six channels.

The use of

magnetic beads as a mechanism of analyte delivery to the localized evanescent field
on the waveguide surface eliminates the need for multiple wash steps and
simultaneously minimizes interference from fluorescing species in the sample matrix
via displacement of matrix volume.

The ease of magnetic bead dispersement in

solution upon removal of the external magnet facilitates regeneration of the
evanescent sensing surface.

In essence, this novel bioassay method has the

advantages of the homogeneous assay, in that measurements can be made in the
presence of the sample matrix, and the heterogeneous assay, in that the analyte is
concentrated on the surface of a solid and mobile substrate. However, unlike regular
heterogeneous assays, assay kinetics resemble liquid phase due to the enhancement of
interaction between magnetic beads and the analyte-containing sample.
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Future work could take advantage of the mass sensing characteristics of this system
to substantially lower detection limits for the bioaffinity systems described herein.
The use of integrated optical waveguides (IOWs) in the place of the bulk, planar
waveguide used in the current work, though complicated in terms of fabrication,
could reduce detection limits up to two orders of magnitude.80

With IOWs, the

waveguide thickness is comparable to the wavelength of propagating light and it is
possible to achieve 104 reflections/cm. However, coupling light into these devices is
quite difficult, normally requiring prisms or gratings. Furthermore, using magnetic
beads that more closely approximate the dimensions of the EW depth could lower
detection limits by maximizing the probed surface area and minimizing matrix
volume in the EW. More sophisticated PDMS architectures could also be utilized for
analysis of maximal numbers of samples.
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